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Public support for measures 
to address alcohol use 
Alcohol consumption
The results of a new survey, Alcohol: Public 
knowledge, attitudes and behaviour,1 show a 
strong belief among 1,020 survey respondents 
(85%) that the current level of alcohol 
consumption in Ireland is too high, and a 
general perception (73%) that Irish society 
tolerates high levels of alcohol consumption. 
The survey was commissioned by the Health 
Research Board and done by Ipsos MRBI.  
A considerable majority of respondents (72%, 
744) say they know someone who, in their 
opinion, drinks too much alcohol, and of those, 
42% say that the person is an immediate family 
member. Almost 6 out of 10 (58%) do not think 
that the government is doing enough to reduce 
alcohol consumption, while only 19% think that 
the government is doing enough. Over three-
quarters (78%) believe that the government 
has a responsibility to implement public health 
measures to address high alcohol consumption, 
and there is support for implementing some of 
the specific measures in the recently published 
Steering group report on a National Substance 
Misuse Strategy.2 
Measuring personal alcohol consumption
People have difficulty measuring their own 
drinking using the standard drink measure, but 
almost 6 out of 10 (58%) have heard of the 
term ‘standard drink’. One in ten respondents 
correctly identified the number of standard 
drinks in each of the four measures of alcohol 
asked about in the survey. Only one in ten (9%) 
people know the recommended maximum 
number of standard drinks (proxy for low-risk 
drinking) that they can safely consume in one 
week, 14 for women and 21 for men. 
Alcohol pricing
Around three-quarters (76%, 777) have bought 
alcohol in a supermarket in the past few years. 
Just over half (52%) of these respondents 
believe that the price of alcohol has fallen in 
supermarkets, with almost one quarter (23%) 
believing that it has remained at the same price 
and 17% believing that the price has increased. 
Of those noticing a decrease in the price of 
alcohol, one-quarter (25%) say that they have 
increased the amount they buy and this is 
more common among those aged 34 years or 
under (at 34%). Overall, 24% would buy more 
alcohol in supermarkets if the price were to 
decrease. Half of those aged 18–24 years claim 
they would buy more alcohol if supermarkets 
decreased prices. 
It would require a 25% price increase to get at 
least two-thirds (67%) of those who bought 
alcohol in a supermarket to reduce the amount 
that they bought. 
Opinion is somewhat divided on whether 
short-term price promotions encourage 
respondents to buy more alcohol than usual, 
with 45% agreeing that they buy more alcohol 
at such times and 39% disagreeing. Those 
aged 18–24 years are most likely to respond to 
such promotions, with almost two-thirds (65%) 
saying that they buy more when alcohol is on 
special offer or when the price is reduced.
Almost 6 out of 10 (58%) respondents support 
minimum unit pricing for alcohol. Support is 
strongest among those aged 35–64 years, at 
65%. Over one-fifth (21%) would not support 
a minimum price for alcohol, with the lack of 
support (at 33%) highest among those aged 
18–24 years. It is generally accepted that the 
greater the increase in alcohol prices the greater 
the reduction in purchasing, and that this has 
most effect on younger and heavy drinkers.
Forty-seven per cent agree that the government 
should reduce the number of outlets selling 
alcohol, while 28% disagree; agreement is 
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strongest among women (50%) and those over 
44 years (54%). Forty per cent agree with selling 
alcohol in separate premises from food and other 
household products, while 32% disagree. The 
majority (66%) believe that distance sales are an 
easy way for young people to obtain alcohol and 
only 15% believe that distance sales are strictly 
monitored.
Alcohol advertising
The majority support restricting certain forms of 
alcohol advertising, and two-fifths (40%) would 
support a ban on all alcohol advertising. Almost 8 
out of 10 (78%) believe that alcohol advertising 
should be limited to the product itself rather than 
being associated with images of the type of person 
who consumes the brand. Eighty per cent support 
banning alcohol advertising in cinemas before 
screening movies rated as suitable for viewing by 
those aged 17 years or under. Seventy-six per cent 
support banning any alcohol advertising on TV 
and radio before 9.00pm. In total, 70% support 
banning alcohol advertising on social media and 
57% support a ban on alcohol advertising on 
billboards and at bus stops 
Alcohol industry sponsoring sporting events
Overall, two-fifths (42%) support a ban on the 
alcohol industry sponsoring sporting events, and 
over one-third (37%) support a ban on sponsoring 
musical events. Support is somewhat higher among 
women (49% for sport and 45% for music) and in 
those 45 years or over (47% for sport and 46% for 
music). The main lack of support for discontinuing 
sponsorship is among men (54% for sport and 57% 
for music) and those under 44 years of age (51% 
for sport and 59% for music). 
Information labels on alcohol products
There is a desire for better labelling of alcohol 
containers, with very strong support for all four 
suggested forms of information on the labels 
of alcohol containers. The vast majority of 
respondents want information on the alcohol 
strength (98%), the number of calories (82%), 
details of alcohol-related harms (95%) and a list of 
ingredients (91%). 
Alcohol consumption and driving
There is good knowledge about the dangers of 
driving a vehicle under the influence of alcohol and 
there is strong support for measures to detect and 
deter such driving practices. Ninety per cent do 
not agree that it is safe to drive after two alcoholic 
drinks; 75% do not agree that it is safe to drive 
after one alcoholic drink. There is near universal 
support (94%) for the mandatory testing of the 
alcohol levels of drivers involved in traffic accidents. 
Over 8 out of 10 (84%) agree that those convicted 
of drink driving on more than one occasion should 
have an ‘alcohol lock’ fitted in their car.
Paying for the consequences of alcohol 
consumption
There is support for the suggestion that alcohol 
consumers and the alcohol industry should 
contribute to the health-related costs of excess 
alcohol consumption. Sixty one per cent believe 
that people who drink alcohol should contribute, 
and 42% believe that the alcohol industry should 
contribute to these costs. Only 27% believe that 
the State, through taxation, should contribute to 
these costs.
As with the health-related costs of excessive 
drinking, the majority believe that those who 
drink alcohol (71%) followed, to a lesser extent, 
by the alcohol industry (30%) and then the State 
through taxation (22%) should contribute to the 
costs of alcohol-related public disorder, relationship 
difficulties and financial loss. 
Conclusions
The findings in this survey are consistent with those 
of the general population survey,3 surveys among 
school children4 and other public opinion surveys.5 
Methods
This survey was conducted for the Health Research 
Board by Ipsos MRBI in May 2012 using a standard 
quota sample method in order to ascertain the 
knowledge, views and behaviours of 1,020 people. 
The age, gender and place of residence of the 
sample selected are representative of the 2011 
Census population. The proportion of people who 
do and do not drink alcohol is consistent with the 
2007 SLAN survey. The questionnaire was drafted 
by the Health Research Board and finalised in 
collaboration with Ipsos MRBI. The HRB asked Ipsos 
MRBI to analyse the questions by gender and age. 
(Jean Long and Deirdre Mongan)
1. Ipsos MRBI (2012) Alcohol: public  
knowledge, attitudes and behaviours.  
Dublin: Health Research Board  
www.drugsandalcohol.ie/18022
2. Steering Group on a national substance misuse 
strategy (2012) Steering group report on a 
National Substance Misuse Strategy. Dublin: 
Department of Health.  
www.drugsandalcohol.ie/16908
3. Morgan K, McGee H, Dicker P, Brugha R, Ward 
M, Shelley E et al. (2009) SLAN 2007: survey of 
lifestyle, attitudes and nutrition  
in Ireland. Alcohol use in Ireland: a profile  
of drinking patterns and alcohol-related  
harm from SLAN 2007. Dublin:  
Department of Health and Children.  
www.drugsandalcohol.ie/12664
4. Hibell B, Guttormsson U, Ahlström S, Balakireva 
O, Bjarnason T, Kokkevi A and Kraus L (2012) 
The 2011 ESPAD report: substance use among 
students in 36 European countries. Stockholm: 
The Swedish Council for Information on 
Alcohol and Other Drugs (CAN) and the 
Pompidou Group of the Council of Europe.  
www.drugsandalcohol.ie/17644
5. Fanning M (2010) Have we bottled it? Behaviour 
and attitudes survey. PowerPoint presentation at 
the ‘Have we bottled it? Alcohol marketing and 
young people conference’ organised by Alcohol 
Action Ireland in Dublin on 15 September 
2010. www.drugsandalcohol.ie/14122
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3The National Documentation Centre on 
Drug Use: survey results
As part of an ongoing evaluation of our website and library 
services, the staff of the National Documentation Centre on 
Drug Use (NDC) recently conducted an online survey of our 
users. We received 441 responses. Thank you to everyone 
who took part. 
Key findings
 ■ Over half (54%) of respondents visit our site at least once 
a month.
 ■ Over half (53%) of respondents currently studying are at 
postgraduate level.
 ■ The majority (73%) of respondents use the NDC for 
work (Figure 1). 
Figure 1 Why do you use the NDC website?
Note: Participants could choose more than one option
In the course of the survey, respondents provided 
observations on various aspects of our resources and 
services. We grouped these comments into the following 
categories:
 ■ Satisfaction with service responsiveness of NDC staff (44 
comments);
 ■ Satisfaction with website and resources (29 comments);
 ■ Literature searching (4 comments);
 ■ Marketing and promotion of the service (5 comments);
 ■ Suggested additions to the service (7 comments).
Satisfaction with service responsiveness
Forty-one per cent of respondents had contacted the NDC 
staff with a query and, of these, 97% were either satisfied 
or very satisfied with the response they received. All 44 
comments about the responsiveness of NDC staff were 
favourable; 30 of them contained the word ‘helpful’. 
Extremely helpful to me in my work & research. One of 
the better elements of service delivery within the overall 
addiction service.
Having used the services and also getting great support 
from your team through telephone support for the past 
two years I have found the service invaluable in my work 
and research. Thank you.
Satisfaction with website and resources
Sixty-one per cent of respondents found the website easy to 
use. All sources of information available from our homepage 
were reported as being useful or very useful by the majority 
of respondents. For example, drug data (treatment tables) 
(78%), evidence-based resources (85%) and the online 
directory of training courses (68%).
Similarly, all our key resource publications were rated as 
useful or very useful by the majority, including our own 
recently updated factsheets (84%), Drugnet Ireland (86%) 
and the annual national reports on the drug situation in 
Ireland (88%).
Comments indicated that respondents were generally 
satisfied with the NDC:
The NDC is a crucial resource for information and research 
on drug and alcohol related publications and debates.
I found this site invaluable for research studies, one of the 
best, and have recommended it too. It is an excellent and 
valuable resource. Thank you for providing a source of 
quality information for all in Ireland and beyond.
Having the resource to use when so many others in Europe 
have been closed down is invaluable.
One respondent wanted more full texts of publications online:
It is an excellent resource, but some texts are unavailable 
online. It would be great if you made more texts available 
online.
Unfortunately, some publications, particularly journal articles 
and books, cannot be made available on our website due 
to copyright law. We do however offer a document delivery 
service where you can request the full text of a published 
article in hard copy.
Literature searching
Eighty-seven per cent of respondents agreed or strongly 
agreed that, overall, the advanced search page was easy to 
use. However, comments confirm that some respondents 
have difficulty in finding what they want, or in sorting search 
results:
It can be confusing and unclear as to how to use the 
search engine and I don’t always get what I need.
Can be difficult to access the relevant information.
The search results need to be better organised especially 
when you try to view all results. It can be extremely 
difficult to identify results when they are all packed 
together.
To address this, we plan to provide an online tutorial on how 
to use the advanced search option. This tutorial will also 
give advice on sorting search results – by year, by author, by 
title or by type of publication. The NDC staff are available 
by telephone or in person (by appointment) to guide you 
through any difficulties you have with searching our site.
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4The need to access regional data was also expressed:
Would be beneficial if research was available or 
searchable based on regional areas. A lot of research is 
national, but if one is trying to get a local picture the 
current format does not allow to categorise research in a 
local regional format.
We have recently added a field in the advanced search page 
called ‘geographical area’ that allows searching by county or 
country. The treatment data can also be searched by county 
or region.
Marketing and promotion of the service
Some respondents would like more regular updates and 
promotion of specific resources:
You need to promote the evidence based research section 
more as I don’t think people use it enough.
More regular updates sent via email to inform users of 
new additions to website.
To keep up to date with alcohol and drug research and 
related issues, you can sign up for the NDC monthly 
electronic newsletter which compiles recent news items 
and new acquisitions, providing links where possible. 
The newsletter also has a link to recent Dáil debates. To 
receive this valuable resource, click ‘NDC newsletter’ on the 
homepage and enter your email address.
Suggested additions to the service
A few respondents made suggestions about features they 
would like to see available from the NDC: 
Tutorial on how to use site displayed prominently on front 
would be useful.
It is useful, much needed. Would like to see update figures 
for drugs etc. and beds available etc.
We plan to produce online tutorials for the key resources on 
our website. We are also looking at ways to make drug-
related data more readily available to our users. We will 
take on board all the suggestions and comments made 
by respondents so that we can continue to improve our 
resources. Thanks again to everyone who took part in our 
survey. The NDC website is at www.drugsandalcohol.ie 
(Mairea Nelson, Mary Dunne and Brian Galvin)
NDC survey results (continued)
Report of the Strategic Response Group 
– ‘A better city for all’ 
The Strategic Response Group (SRG) is a partnership set up 
to address public substance misuse and perceived anti-social 
behaviour in Dublin city centre. In June 2012, following a 
year-long process of research and consultation, it published 
a report aimed at addressing this issue in the long term.1 
The report was officially launched by the lord mayor of 
Dublin, Councillor Andrew Montague, in one of his last 
engagements as mayor. The issue of anti-social behaviour 
related to substance misuse in Dublin city centre has long 
been a focus of media attention and public concern. 
The outgoing mayor of Dublin, Cllr Andrew Montague, launches the SRG report in the Oak Room of the Mansion House; 
also shown are SRG members (l to r): Mel MacGiobhúin, North Inner City LDTF; Richard Guiney, Dublin City BID; Niamh 
Randall, Dublin Simon Community; Des Crowley, City Clinic Amiens Street; and Ruaidhrí McAuliffe, UISCE.
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Business Policing Forum, this issue became a recurring item 
of discussion. A number of agencies and organisations were 
invited to make presentations on the topic. Arising from this, 
the Strategic Response Group (SRG) was formed with the 
objective of developing ways to build sustainable street-
level drug services and address related public nuisance. The 
SRG is independently chaired and its membership includes 
representatives of: the four main drug treatment centres in 
Dublin city centre (Ana Liffey Drug Project, the City Clinic, 
Drug Treatment Centre Board, Merchants Quay Ireland); An 
Garda Síochána; Dublin City Business Improvement District; 
Dublin City Council; Dublin Simon Community; the North 
Inner City Local Drugs Task Force; the South Inner City Local 
Drugs Task Force and the Union for Improved Services, 
Communication and Education (UISCE).
The SRG commissioned a study to provide an evidence base 
to assist it in developing its response and recommendations.2 
The study used a Rapid Assessment Research (RAR) method 
to assemble an evidence base around perceived anti-social 
behaviour associated with the provision of drug treatment 
in Dublin’s city centre upon which to build a strategic 
response incorporating short/medium/long term goals and 
actions within the area. The RAR combined various research 
methods and data sources in order to construct an overview 
of the problem by cross-checking and comparing the 
information from several different sources, which included 
the following:
 ■ A critical review of literature.
 ■ PULSE data for the research area was analysed and 
provided by An Garda Síochána.
 ■ A mapping exercise inclusive of an environmental 
visual assessment using digital photographs to view 
the geographical distribution of drug- and alcohol-
related public nuisance was undertaken to assess levels 
of ‘hotspots’ for public nuisance, anti-social drug- and 
alcohol-using congregations, drug-related littering, 
alcohol retail outlets and placement of drug treatment, 
housing, policing and community services in the area.
 ■ Interviews and focus groups were conducted with 
business and transport stakeholders (n=19), community, 
voluntary and statutory stakeholders (n=19), and service 
users (n=23). Random street intercept surveys were 
conducted with passers-by (n=25) and with drug users 
(n=26). 
Research limitations
The research is exploratory and limited by small sample 
size. However, despite the small numbers of participants, 
the validity and accuracy of the findings are optimised 
by the use of triangulated data sources from PULSE data 
relevant to the area, service-user perspectives, business and 
transport, community, voluntary and statutory stakeholder 
perspectives, passers-by and street problematic drug-user 
perspectives, photographical and environmental mapping 
analysis. 
Key findings
Definitions and experiences of anti-social behaviour
A continuum of acceptable versus non-acceptable forms of 
public behaviours, and level of impact between anti-social, 
nuisance and criminal elements of the behaviours was 
described in the research. A range of definitions of anti-
social behaviour was recorded in the interview narratives, 
with anti-social behaviour deemed to be (typically) illegal, 
causing interference, visual and physical intimidation, and 
feeling unsafe, impacting negatively on businesses, services, 
customers, tourists and individuals accessing the area 
whether on foot, in private transport or on public transport. 
Particular anti-social activities mentioned included; visible 
drinking and drug use, intoxication, aggressive and loud 
behaviour, youth and child drinking and drug dealing on 
the streets, phone snatching, graffiti, night-time alcohol 
abuse, mobile phone theft, harassment, street assaults, 
begging/’tapping’ on the street and at Luas ticket machines, 
car break-ins, pick-pocketing and other petty crimes. Pulse 
data reflected drug crime detections which correspond 
closely with typical business hours, peaking between the 
hours of 10am and 5pm. A clear distinction between specific 
quadrants is presented in terms of crime profile, which 
corresponds to the predominant commercial activity of 
these areas, retail and night-time entertainment respectively. 
Quadrant 6 is significantly different to all other areas of the 
study, due to the inclusion of Temple Bar, which has its own 
specific crime profile. Property crime is associated with the 
retail areas and public order offences are associated with the 
night-time entertainment areas. 
Perceptions of threat and intimidation in the research area
Negative media portrayal of anti-social behaviour in the 
research area was described. The urban design and poor 
lighting of certain streets was mentioned in the interviews 
and focus groups as contributing to perceptions of fear 
and lack of safety. Tourists and visitors who were spoken to 
during ‘walkabouts’ in the research area had not observed 
any forms of anti-social behaviour, and reported feeling safe 
and happy with the Garda presence in the area. However, 
those working in the area had all observed anti-social 
behaviour, had felt intimidated, and reported feeling unsafe 
in the area both during the day, and at night time. 
The SRG, in seeking to address perceptions of drug-related 
crime and anti-social behaviour, acknowledges that for 
historical reasons there is a clustering of drug treatment 
and homelessness services in or adjacent to the inner city. 
While these services play a major role in the provision of 
effective treatment to problematic drug users, the report 
recommends that there should be greater access to 
prompt provision of treatment options nationally and that 
people should be treated and accommodated in the most 
appropriate setting for their circumstances and provided 
with support services as close to their home as possible.
The report takes a holistic approach to addressing 
the issues of the city centre. The group has set out its 
recommendations in the short, media and long term 
and under the headings of treatment, rehabilitation, 
homelessness, policing responses, planning and urban 
design, legislation and regulation and implementation. The 
SRG is currently developing an implementation plan for its 
recommendations.
(Johnny Connolly)
1. Strategic Response Group (2012) A better city for all: a 
partnership approach to address public substance misuse and 
perceived anti-social behaviour in Dublin city centre. Dublin: 
Strategic Response Group.  
www.drugsandalcohol.ie/17769
2. An executive summary of the research is provided in the SRG 
report. The SRG intends to publish the full report at a later 
date.
Report of Strategic Response Group (continued)
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In the past few months the European Commission (EC)1 and 
the European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA)2 have published reports intended to inform the 
development of the next EU drugs strategy, which the European 
Council is due to adopt by the end of 2012.3 Although drug 
policy lies within the competence of individual member states,4 
the EU drugs strategy can play an important role by supporting 
and providing guidance to member states.
The independent assessment commissioned by the EC concludes 
that there has been ‘little change in the demand for and 
availability of drugs in the EU’ over the lifetime of the current 
EU drugs strategy, and drug-induced deaths have remained 
at ‘historically high levels’. The authors state that they cannot 
conclude that any improvements in the EU drugs situation have 
been ‘unequivocally’ due to the implementation of the strategy. 
Comparing trends in 2011 with trends that were emerging 
in 2004, when the current strategy was being developed, the 
EMCDDA also suggests little has changed: ‘… many of the 
problems and solutions seen as pertinent in 2011 have their 
roots in 2004 or earlier’ (p. 11). (A summary of the EMCDDA 
trend report 2011 is provided in a separate table in this issue of 
Drugnet Ireland.)
The authors of the independent assessment commissioned by 
the EC conclude, however, that the EU drugs strategy has had 
a ‘discernible impact on the process of drugs policy formulation 
and adoption in individual member states’, with the content and 
structure of national policy documents converging with the EU 
strategy, and the process of evaluating, revising and updating 
national drugs policy documents becoming a more firmly 
embedded and common practice. The authors also argue that  
a drugs strategy at EU level can add ‘considerable value’  
at national level because it supports and strengthens 
international co-ordination and co-operation between  
member states, and because the mutual learning and  
exchange of best practice eliminates the need to reinvent  
the wheel. In short, the strategy has:
… provided a forum and a decisionmaking process for 
consensus building, developed a shared language and 
understanding and provided a platform for information 
sharing and mutual learning. (p. 96)
In May 2012 the European Council issued its preliminary 
conclusions with regard to these two reports and the shape of 
the next strategy.5
Policy framework
Although the independent assessment called for a shorter-term 
strategy with a reduced number of priorities and an integrated 
action plan, the Council has expressed a preference for the same 
format as before: 
 ■ an eight-year strategy (2013–2020); 
 ■ the same five thematic areas – coordination, demand 
reduction, supply reduction, international cooperation, and 
research, evaluation and information; 
 ■ implementation organised through two consecutive four-
year action plans; and 
 ■ ‘an integrated, multidisciplinary and balanced approach’. 
The Council proposes that each Presidency will prepare an 
overview of progress against the action plan, in other words, 
a six-monthly progress report, and an evaluation will be 
undertaken at the expiry of each action plan and of the strategy. 
Challenges and threats
The European Council lists the ‘challenges’ and ‘threats’ that 
should be prioritised in the new strategy as follows:
 ■ polydrug use, including the combination of illicit drugs and 
alcohol, 
 ■ the rapid spread of new psychoactive substances,
 ■ ensuring access to and addressing the misuse of prescribed 
controlled medications,
 ■ the dynamics in the drug markets, including the use of the 
internet as a facilitator for the distribution of illicit drugs,
 ■ the diversion of precursors used in the illicit manufacture of 
drugs,
 ■ the quality of demand reduction services, and
 ■ the high incidence of blood-borne diseases, especially HCV, 
among injecting drug users and potential risks of outbreaks 
of HIV epidemics and other blood-borne infections related to 
injecting drugs use.
Despite a recommendation in the independent assessment that 
an integrated policy approach across illicit and licit substances 
(including ‘legal highs’, alcohol and cigarettes) be developed, 
the Council did not include this in its list of challenges to be 
addressed in the next seven years.
Supply reduction
Activities under this pillar will remain focused on co-operation 
between law enforcement authorities, including exchange of 
information and joint operations and investigations, and on 
co-ordination of law enforcement initiatives. The Council sees a 
need to expand and improve the knowledge base around supply 
reduction and to develop accurate indicators of progress. 
Demand reduction
As in the previous strategy, the demand reduction pillar will 
cover the whole gamut of demand reduction interventions, 
including special initiatives in prison settings and steps to 
improve quality standards. The Council acknowledges that 
there has been some success in promoting an evidence-based 
approach. However, it sees a need for greater uniformity 
across all member states in implementing harm reduction and 
treatment measures. Moreover, member states need to meet 
the persistent challenges with regard to implementation and 
co-ordination of national strategies, particularly in an economic 
downturn.
In a separate article in this issue of Drugnet Ireland, alternative 
approaches to developing EU-level drug policy are outlined. 
(Brigid Pike)
1. Culley DM, Skoupy J, Rubin J, Hoorens S, Disley E and 
Rabinovich L (2012) Assessment of the implementation of the 
EU drugs strategy 2005–2012 and its action plans. Technical 
Report prepared for European Commission Directorate 
General for Justice. Santa Monica, CA: RAND Corporation. 
www.drugsandalcohol.ie/17312
2. EMCDDA (2011) EMCDDA trend report for the evaluation of 
the 2005–2012 EU drugs strategy. Lisbon: EMCDDA. 
3. See account of process in Pike B (2012) EU drug policies 
under review in 2012. Drugnet Ireland, (41): 8. Available at  
www.drugsandalcohol.ie/17269
4. This is known as the principle of ‘subsidiarity’.
5. Council of the European Union (25 May 2012) Draft 
Council conclusions on the new EU drugs strategy. 10231/12 
CORDROGUE 37 SAN 121 ENFOPOL 145 RELEX 455. http://
register.consilium.europa.eu/pdf/en/12/st10/st10231.en12.pdf
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of the 2005–2012 EU drugs strategy
Main trends and changes in the European drug situation and in the responses developed by the EU member states, 
2005–2012*
Strategic pillar and aim Finding
Drug use and drug-related problems
A measurable reduction in the use of 
drugs, of dependence and of drug-related 
health and social risks
 ■ Heroin still the biggest problem drug
 ■ HIV risks low, but ongoing risk of outbreaks among drug injectors
 ■ HCV levels high but modest declines in new cases
 ■ High and stable numbers of drug-induced deaths
 ■ Cocaine levels steady or decreasing in high prevalence countries and low 
elsewhere
 ■ Methamphetamine partly replaces amphetamine in some northern 
European countries
 ■ Cannabis use stable or reducing but continues to be Europe’s most popular 
drug
 ■ Gradual increase in number of cannabis and cocaine users entering 
treatment
 ■ GHB, ketamine generally low prevalence, higher in certain sub-groups
Drug supply and new drugs
A measurable improvement in 
effectiveness, efficiency and knowledge 
base of law enforcement interventions 
and actions targeting production, 
diversion of precursors, drug trafficking 
and the financing of terrorism, and money 
laundering
 ■ Evidence of both stability and droughts in the heroin market
 ■ Diversification in cocaine trafficking routes and methods
 ■ Increasing domestic production of cannabis
 ■ Scarcity and possible bounce-back for MDMA
 ■ Increasing sophistication in techniques to bypass precursor rules
 ■ Record numbers of new psychoactive substances notified
 ■ Increase in number of ‘legal highs’ available in Europe
Drug policies
Ensure a balanced and integrated 
approach is reflected in national policies 
… evaluations should continue to be an 
integral part of an EU approach to drugs 
policy
 ■ National drugs strategies in place
 ■ Increasing evaluation of drug policies
 ■ Trends towards lower penalties for possession
 ■ Innovation in policy responses to ‘legal highs’
 ■ Impact of recession on Europe’s drug responses – not possible to assess 
exact impact as yet
Drug demand reduction
The development and improvement of an 
effective and integrated comprehensive 
knowledge-based demand reduction 
system including prevention, early 
intervention, treatment, harm reduction, 
rehabilitation and social reintegration 
measures
 ■ Slow take-up of evidence-based prevention approaches
 ■ Opioid substitution treatment (OST) provision in all member states
 ■ OST coverage varies widely
 ■ Core harm reduction interventions in all countries
 ■ Drug-related problems in prison increasingly targeted
 ■ Increasing use of guidelines and standards in Europe
Source: EMCDDA (2011) EMCDDA trend report for the evaluation of the 2005–2012 EU drugs strategy. Lisbon: EMCDDA.  
This report was compiled as a supporting document for the evaluation of the 2005–12 EU drugs strategy and its two action 
plans: 2005–08 and 2009–12. 
*Table compiled by Brigid Pike
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policy
Just as the European Council was agreeing the broad 
parameters of the EU’s next drugs strategy (see separate 
article in this issue), the UK’s House of Lords and the EU’s 
Civil Society Forum on Drugs (CSF) published their views on 
how the EU should tackle the drugs issue. Their conclusions 
differ from those of the European Council.
House of Lords1
The House of Lords EU Committee invited written and 
oral submissions on what had been achieved by the EU 
drugs strategy 2005–2012 and what should come next. 
The committee also collected evidence during visits to 
Brussels (Commissioner for Justice, Fundamental Rights and 
Citizenship) and Lisbon (European Monitoring Centre for 
Drugs and Drug Addiction). While acknowledging the value 
of an EU-level policy framework for illicit drugs in providing 
guidance to member states, the committee believes that 
the aims of demand reduction and supply reduction are 
‘too broadbrush to be useful’. It recommends that the new 
strategy should concentrate on three areas where the EU can 
make a difference (p. 47):
1. Coordination of the fight against drug trafficking – on 
the legislative front, the EU should focus more closely 
on money laundering and strengthen provisions on 
the seizure of the proceeds of crime, while on the 
operational and research fronts, efforts should continue 
to be supported. The committee concludes: ‘We believe 
that working on these fronts will be more productive 
than revising existing legislation on maximum penalties 
and newly developed psychoactive substances’ (p. 5).
2. Information – the strategy should concentrate on the 
improvement of the collection, analysis, evaluation and 
distribution of information so that member states, while 
retaining the freedom to formulate their own policies, 
can learn from each other‘s experiences and benefit from 
each other’s research. 
3. Public health orientation – impressed by the evidence of 
the effectiveness of Portugal’s public-health-orientated 
national drugs strategy, the committee recommends the 
strategy should cite the EU’s public health obligations to 
encourage all member states to include harm reduction 
measures in their national policies. The committee 
concludes: ‘It should be recognised that health policy is as 
important as law enforcement policy in this field and that 
education also has an important role to play’ (p. 46).
In responding positively to the recommendations of the 
Committee, the British government emphasised that a 
public health orientation should focus not just on harm 
reduction measures but also on ‘sustained recovery’:2
We would view it as a missed opportunity were a new 
EU Drug Strategy to restrict its discussion of treatment 
to harm reduction measures alone. The UK in common 
with other Member States is keen for people to achieve 
sustained recovery from drug dependence, and a new 
EU Drug Strategy should contribute to that goal too. 
We recognise that each individual recovery journey will 
be unique and that for some individuals, medicinally-
assisted recovery may be part of that journey.
Tackling drug dependence should remain a key strand of 
the EU Drugs Strategy as an important crime reduction, 
public health and wider public impact issue. It is only 
through getting individuals off drugs for good that a 
permanent change occurs which results in them ceasing 
offending, stopping harming themselves and their 
communities and successfully contributing to society.
Civil Society Forum on Drugs (CSF)3
Set up in 2007 by the European Commission and currently 
comprising 35 member organisations, the CSF serves as a 
platform for the informal exchange of views and information 
between the European Commission and civil society 
organisations in the EU. It represents a diverse group of 
European organisations (none from Ireland) that provide 
health and social services, advocate for more effective drug 
policies, and represent affected communities. Its proposals 
for the new strategy were produced following a one-year 
consultative process and represent a consensus position.
The document lists nine ‘general principles for drug policies’ 
and makes 16 recommendations for action related to 
these principles. Issues particularly highlighted by the CSF 
are respect for human rights, and targeting the needs of 
vulnerable groups, including those experiencing poverty, 
deprivation, social inequality, discrimination and stigma; 
children and young people; and problem drug users. It also 
promotes the ‘minimum quality standards’ for drug demand 
reduction programmes developed within the EQUS project.
General principles (and recommendations)
1. Drug policies and practices must be balanced, 
integrated, evidence based and focused on public health. 
(Recommendation 5)
2. Human rights must be fully respected in drug policies 
and practices and all drug control activities that are 
undertaken or promoted should be in line with human 
rights obligations including those under the relevant EU 
and UN Charters, including EU Charter of Fundamental 
Rights. (Recommendations 10 and 11)
3. Drug policies should renew their focus and attention 
onto the needs of vulnerable groups. This includes 
but is not exclusive of people who use drugs, young 
people and children, as well as women, migrants and 
mobile populations, prisoners, sex workers, LGBT people 
exposed to environments where drug use occurs and 
members of social-economic vulnerable communities 
who may be disproportionately affected by drugs and 
drug policies. (Recommendations 4, 12 and 14)
4. Drug policies should renew their focus on evidence 
based demand reduction approaches, including 
prevention, early intervention, treatment, harm 
reduction, rehabilitation and social reintegration. 
(Recommendation 5)
5. There should be more coherence between drug policies 
and practices. This entails that drug policies should  
be fully implemented in practice, and practice should  
be routinely monitored and evaluated, with 
lessons learnt incorporated into policy as needed. 
(Recommendation 13)
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96. Drug policies should incorporate learning and sharing 
of knowledge and experience across local, national, EU 
and international levels in order to improve drug policies 
according to evolving practices and knowledge. 
7. More emphasis should be given to providing drug 
related services within the criminal justice system, 
including continuation of services and interventions 
during the post-release period. (Recommendations 6, 7,8 
and 9)
8. Drug policies should be developed and implemented 
at the EU level through improved coordination of all 
relevant stakeholders, including Member States, relevant 
Directorates-General, the European Parliament and civil 
society. (Recommendation 3)
9. Evaluation should be considered as an essential element 
of effective drug policy. (Recommendation 15)
ENCOD (European Coalition for Just and Effective Drug 
Policies), a member of the CSF, did not sign the document 
because it considered the proposal should have included a 
reference to alternatives to prohibition. Seventeen NGOs 
supported a separate statement on the need to decriminalise 
the possession of drugs for personal use.4 
(Brigid Pike)
1. House of Lords European Union Committee (2012) The EU 
drugs strategy report. 26th report of session 2012–2012. HL 
Paper 270. London: The Stationery Office Ltd. 
2. Henley, Lord, Minister of State for Crime Prevention and 
Anti-Social Behaviour Reduction (2012) EU drugs strategy: 
government response to each of the recommendations. Letter 
and attachment containing the UK government’s response 
to the House of Lords Committee recommendations. 
London: Home Office. 
3. Civil Society Forum on Drugs (April 2012) Proposal to the EU 
member states and the European Commission for inclusion in 
the new EU drugs strategy and action plan. Available at  
www.drugsandalcohol.ie/18220
4. Sarosi P (2012, 20 April) ‘Civil society demands 
involvement’. Item submitted by ‘sarosip’ to  
Drug Reporter, the drug policy website of the  
Hungarian Civil Liberties Union. Accessed 27 June  
2012 at http://drogriporter.hu/en/csfd2012apr
Alternative ways forward for EU drugs policy (continued)
Measuring the performance of drugs 
task forces and evaluating projects
In September 2011 the Minister of State in the Department 
of Health with responsibility for Primary Care, Róisín Shortall 
TD, initiated a review of drugs task forces. In October 
a consultation process was initiated with government 
departments and statutory bodies, with community and 
voluntary bodies and with the drugs task forces (DTFs), 
and in February 2012 an interim report summarising the 
responses of these three groupings to six ‘key questions’ was 
issued.1 Responses with regard to the questions about key 
performance indicators (KPIs) and evaluation of projects are 
summarised below. 
What are the key performance indicators that we need 
for drugs task forces?
The responses of the three categories of respondents to 
this question differed considerably. Respondents from 
departments and statutory agencies believed that the KPIs 
in the National Drugs Strategy (NDS) could form the basis 
for measuring the performance of DTFs, and that the annual 
work plans of the DTFs should be examined to determine 
the extent to which DTFs have achieved their objectives 
and delivered outcomes. They also suggested that agencies 
and projects funded through the DTFs should provide 
information on their local area to enhance analysis and 
performance assessment, and that the provision of this data 
should be a condition of funding. Finally, they suggested 
data on the following topics could facilitate performance 
measurement:
•	 outputs and outcomes, including evidence of 
progression and individual achievement;
•	 reasons for exit from treatment;
•	 number of treatment centres and barriers to access, if 
any;
•	 number of rehabilitation places;
•	 number of prevention projects being undertaken;
•	 number of awareness programmes developed;
•	 number of arrests; and
•	 number of seizures.
Respondents from the community and voluntary sectors 
advocated the development of a valid and reliable outcome 
measurement system, with targets not just for outputs, but 
for short and medium term impacts, and KPIs established for 
each area. They also recommended that DTFs adopt a logic-
model approach to their work based on implementation of 
the NDS. Respondents from the community and voluntary 
sectors suggested a series of process-oriented KPIs:
•	 extent to which DTFs provide accessible information on 
drug use and misuse services;
•	 extent to which a DTF is community-focused;
•	 extent to which a DTF makes strategic decisions in the 
funding of projects;
•	 evidence that the local/regional plan is linked to the 
NDS;
•	 evidence that the DTF network is influencing policy;
•	 evidence of how DTFs share information and promote 
best practice;
•	 evidence of DTF involvement in other social inclusion 
initiatives;
•	 percentage of funding spent directly to help drug 
misusers and recovering drug users;
•	 extent of community engagement in DTF principles, 
goals, plans and strategies;
•	 increase in local leadership and local capacity; and 
•	 level of allocation of resources to community 
engagement activities.
Respondents from among the DTFs noted that while there 
are KPIs for DTFs in the NDS, these KPIs are designed 
to measure the effectiveness of the NDS (including the 
co-ordination function), and not the performance of any 
one agency. Therefore, DTF respondents proposed the 
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following KPIs, including a mix of both process and content 
measurements:
•	 adequacy and appropriateness of representation on 
DTFs;
•	 responsiveness of DTFs at local level to national 
decisions;
•	 interagency working, local coordination and 
participation, level of project staff involvement;
•	 impact of DTF on communities;
•	 qualitative and quantitative measures of Treatment 
outcomes, e.g. client numbers, waiting times; 
programme retention and completing times;
•	 qualitative and quantitative measures of emerging drugs 
use trends;
•	 process indicators
•	 compliance with QuADS;
•	 training results;
•	 health monitoring;
•	 value for money.
Respondents from this category suggested that a small 
group of task force co-ordinators be established to devise 
KPIs along the lines of Provan and Milward’s framework.2  
It was also proposed that the DTF forms should be evidence-
based and follow a logic model.
How could we achieve a standardised evaluation of drugs 
task force projects?
There was a general consensus among respondents 
from all three categories that a standardised evaluation 
mechanism for DTF projects is needed; respondents from 
among the DTFs also called for a common reporting/
evidencing framework. It was suggested that the Drugs 
Programmes Unit in the Department of Health should 
develop an evaluation tool in ‘close consultation’ with DTFs 
and the channels of funding, and that, rather than trying to 
reinvent the wheel, existing tools, e.g. from the EMCDDA 
best practice portal or the WHO, should be used as a 
starting point. Other suggestions were that the evaluation 
tool should be based on the objectives of the core work 
of the funded projects and linked to the objectives of the 
relevant DTF, e.g. through use of the LDTF 1 form; that 
the theory of change and/or logic model should provide 
the basis for a standard evaluation tool; that a logic-based 
evaluation template should be developed to reflect the 
QuADS standards; and that a common web-based computer 
database with standardised questionnaires and agreed KPIs 
for DTFs and projects be adopted.
Evaluation criteria based on the following types of evidence 
were suggested by one statutory agency:
•	 appropriateness of drug-focused interventions;
•	 strategic fit with NDS actions, DTF work-plan and fitness 
for purpose;
•	 range and type of activities/services delivered;
•	 progression and individual achievements;
•	 impact on the individual service user and added value to 
community; and
•	 project capability and sustainability. 
Respondents from among the DTFs also suggested that it 
was important to measure the work being done by workers, 
as well as changes in clients and families. The use of new 
technology, such as the client relationship management 
system being researched by some DTFs, was mentioned in 
this regard. 
Final report
The final report and recommendations are still awaited. 
In thinking about how performance measurement and 
evaluation systems may develop in the future, it should be 
borne in mind that the interim report states that one priority 
of the review is to identify where it would be appropriate to 
transfer responsibility for projects to statutory agencies, thus 
reducing the number of projects supported by DTFs in the 
future. 
(Brigid Pike)
1. Drugs Programmes Unit (2012) Report on the consultation 
process in relation to the review of the structures underpinning 
the National Drugs Strategy. Dublin: Department of Health. 
www.drugsandalcohol.ie/17027 
2. Provan K and Milward HB (2001) Do networks really work? 
A framework for evaluating public-sector organizational 
networks. Public Administration Review, 61(4): 414–423.
Measuring performance and evaluating projects (continued)
National survey of youth mental health 
Researchers at University College 
Dublin and Headstrong, the non-profit 
support organisation, completed a 
national survey which examined youth 
mental health.1 The researchers 
estimated the proportion of young 
people experiencing common mental 
health problems and explored the 
known risk and protective factors that 
are associated with mental health 
status. The survey population 
comprised second-level students aged 
12–19 years (6,085) and young adults 
aged 17–25 years (8,221). In total, 
14,306 participants completed 
questionnaires. Fifty-one per cent of 
the participants randomly selected at 
second-level schools were female, and 
65% of young adults purposively 
selected through third-level colleges, 
employers, training centres and 
unemployment centres were female. 
The main findings revealed that the 
majority of young people (aged 
12–25) were functioning well, but that 
sizeable proportions experienced risk 
factors. 
 ■ One in ten second-level students 
and between 12% and 16% of 
young adults reported high-levels 
of anger. 
 ■ Five per cent of second-level 
students and 10% of young adults 
were very or severely stressed. The 
main sources of stress for second–
level students were school, friends 
and family, and for young adults 
were college, money, work and 
family. 
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 ■ Eleven per cent of second-level students and 14% of 
young adults had severe or very severe anxiety. 
 ■ Eight per cent of second-level students and 14% of 
young adults had severe or very severe depression. 
 ■ A small proportion second-level students reported 
avoidance strategies. 
 ■ Two-fifths of second-level students experienced bullying 
at some point in their life and 77% of bullying episodes 
occurred at school.
 ■ Five per cent of second-level students ranked themselves 
at the bottom of their class and these students were 
more likely to experience anxiety and depression. 
 ■ One-fifth of young adults had deliberately hurt 
themselves at some point in their life and seven per cent 
had attempted suicide. 
Alcohol was used by considerable proportions of young 
people, and those who consumed alcohol drank it in 
an unhealthy manner. Alcohol users were more likely to 
experience severe forms of stress, anxiety and depression 
than their non-drinking counterparts. 
 ■ Four-fifths (79%) of second-level students (aged 12–19 
years) consumed alcohol within the normal adult limits 
(below 8 on the AUDIT scale). 
 ■ One-fifth (21%) of second-level students consumed 
alcohol in excess of the normal adult limits (8 or above), 
with 15% scoring as problem drinkers, 3% as hazardous 
or harmful drinkers and 3% as dependent drinkers.
 ■ Two-fifths (39%) of young adults (aged 17–25 years) 
were classified as drinking within safe limits;
 ■ Three-fifths of young adults were classified as drinking 
in excess of normal limits, with 41% scoring as problem 
drinkers, 10% as hazardous or harmful drinkers and 10% 
as dependent drinkers. 
 ■ Binge drinking (drinking six or more standard alcoholic 
drinks, 60g, in a single sitting) was common among 
both second-level students and young adults  
(Figure 1). Binge drinking weekly or more often 
increased with increasing age up to 21 years and then 
decreased somewhat. 
 ■ At least eight per cent of the young people in this study 
aged 14–25 years drank 10 or more standard drinks on 
a typical drinking day. Drinking 10 or more standard 
alcoholic drinks on a typical drinking day is an indicator 
of harmful or dependent drinking.
Figure 1 Proportion of survey respondents who 
consumed 60 grams of alcohol or more  
in a single sitting weekly or more often 
(binge drinking), by age
Cannabis use was less common than alcohol use. 
Nevertheless considerable proportions reported using 
cannabis at some point in their life and its use increased with 
increasing age (Figure 2). Forty-five per cent of young adults 
(aged 17–25) used cannabis. Young adult males (52%) 
were more likely to report cannabis use than their female 
counterparts (42%). Over three quarters (77%) reported 
that they took cannabis for the first time between 15 and 19 
years of age. 
Figure 2 Lifetime prevalence of cannabis use among 
survey participants, by age
A six-item, yes/no response scale called CRAFFT was used to 
measures levels of substance misuse; a score of 2 or more 
indicates a high level of substance misuse. One-quarter of 
second-level students and half of the young adults scored 2 
or more on the CRAFFT scale. 
Self-esteem, optimism, resilience, problem solving and social 
networks were the protective factors associated with mental 
health. Having support from a special adult was beneficial. 
(Jean Long)
1. Dooley B and Fitzgerald A (2012) My world survey: national 
study of youth mental health. Dublin: UCD and Headstrong. 
www.drugsandalcohol.ie/17589
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Deaths among children and young 
people in state care, after care or known 
to the HSE
In June 2012 the report of the Independent Child Death 
Review Group (ICDRG) was published.1 The review group 
investigated the deaths (between 1 January 2000 and 30 
April 2010) of 196 children and young people who were in 
care, in receipt of aftercare or known to the child protection 
services in Ireland at the time of their death. Of the 196 
deaths, 112 were due to non-natural causes. The breakdown 
of deaths over the ten-year period was as follows:
Children (aged 4–17 years) in care: 36 deaths 
 ■ 19 deaths from natural causes
 ■ 17 deaths from non-natural causes
Young people (aged 18–23 years) in aftercare: 32 deaths
 ■ 5 deaths from natural causes
 ■ 27 deaths from non-natural causes
Children (aged <1–17 years) known to the HSE: 128 
deaths
 ■ 60 deaths from natural causes
 ■ 68 deaths from non-natural causes
The ICDRG examined the files and reports of the HSE in 
respect of all 112 children and young people who died of 
non-natural causes and provided a comprehensive case 
summary for each individual, together with summaries of 
aspects of good practice and causes for concern in each 
case. 
The ICDRG found that 17 of the 112 children and young 
people had a history of problem alcohol use and 29 a history 
of problem drug use. Thirty (27%) of the 112 non-natural 
deaths were directly drug-related, and of these, the greatest 
proportion occurred among young people in aftercare:
 ■ children (aged 4–17 years) in care: 5 (29% of 17 deaths 
in this category)
 ■ young people (aged 18–23 years) in aftercare: 14 (52% 
of 27 deaths)
 ■ children known to the HSE (aged <1–17 years): 11 (16% 
of 68 deaths)
The review group did not give details as to which drugs 
caused the deaths. 
The other causes of non-natural death were:
 ■ 28 (25%) owing to suicide;
 ■ 17 (15%) owing to road traffic collisions;
 ■ 16 (14%) were unlawfully killed; and
 ■ 21 (19%) owing to other accidental or unknown causes.
Many of the 196 children had also lived with problem 
alcohol use (n=37) or problem drug use (n=19) in the home. 
The ICDRG noted the HSE was aware of drug and alcohol 
misuse problems among the families:
… the HSE was aware of drug and alcohol abuse within a 
number of families, in particular by parents, which must 
as a natural consequence have given rise to concerns as 
to the welfare of the children, yet the HSE closed their 
files in a number of these cases despite the drug and 
alcohol abuse continuing. Children are vulnerable by 
their very nature and not to continue to attend to these 
issues and the implications for their welfare is to expose 
them to too great a risk of harm. Risk indicators such as 
this were not followed up adequately, or at all, by the 
HSE in a number of the files. In some cases no social 
worker was assigned to these families. (p. xxiii)
The ICDRG made the following recommendations with 
regard to how social workers should involve drug and 
alcohol services, and conversely how drug and alcohol 
services should work with the child welfare and protection 
services: 
In a significant number of cases, it was evident that 
drug and/or alcohol abuse by parents was having a very 
damaging effect on their ability to consistently parent 
their child. Indeed, in some cases, drug and/or alcohol 
abuse was the key factor in the child/young person 
being referred to the HSE or being taken into care. This 
is a problem which has to be tackled. When a Social 
Worker comes into contact with a family where drug/
alcohol abuse is significantly disrupting familial life, 
it is essential that such abuse is addressed in a robust 
manner. The effect on the children has to be recognised 
and the parents must be made aware of the support and 
treatment options that are available. Parents must be 
encouraged and enabled to take up those supports.
Furthermore, drug and alcohol services must be actively 
integrated into the child protection system. These 
services have the capacity to alert Social Workers to 
potentially devastating events happening between 
parents with drug and/or alcohol problems and their 
children often before the children are ever referred to the 
HSE. There must be open channels of communication 
between drug and alcohol services and the child 
protection system so that where these services become 
aware of child protection concerns, this information 
is quickly conveyed to the child protection system. 
The planning around these children and families must 
actively engage each part of the system. (p. 409)
The ICDRG report is not the first to highlight the 
vulnerability of children and young people, particularly 
those leaving state care. The plan to implement the 
recommendations contained in the Ryan Report (the 
report of the Commission to Inquire into Child Abuse) 
acknowledged the association between state care and future 
poor outcomes for children:2
Those with a care history continue to be over-
represented among those who are, for example, 
accessing addiction services, coming into contact 
with the criminal justice system and experiencing 
homelessness in adulthood. (p. xii)
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The implementation plan included an appraisal of the gaps 
in service provision around pre-release planning and called 
on the HSE to ensure that care plans included aftercare 
planning for all young people of 16 years and older (Action 
67). The implementation plan also highlighted the gaps in 
aftercare services for young people. While acknowledging 
that some attempts to provide aftercare had been effective 
in the past, it stated: 
Aftercare services are not provided consistently to 
all children across the State. Some HSE areas have 
dedicated aftercare workers, but most do not. …The 
provision of aftercare by the HSE should form an integral 
part of care delivery for children who have been in the 
care of the State. It should not be seen as a discretionary 
service or as a once-off event that occurs on a young 
person’s 18th birthday, but rather a service that he or she 
may avail of up to the age of 21. (p. 48) 
The implementation plan included two actions to provide 
for, and monitor the provision of, an enhanced system of 
aftercare, which, if implemented consistently and effectively, 
would contribute to a reduction in youth homelessness and 
a concomitant reduction in exposure to substance use. 
Action 64: The HSE will ensure the provision of aftercare 
services for children leaving care in all instances where 
the professional judgment of the allocated social worker 
determines it is required. 
Action 65: The HSE will, with their consent, conduct a 
longitudinal study to follow young people who leave 
care for 10 years, to map their transition to adulthood. 
(Brigid Pike)
1. Shannon G and Gibbons N (2012) Report of the independent 
child death review group 2000–2010. Dublin: Government 
Publications. Available at www.drugsandalcohol.ie/17774 
2. Office of the Minister for Children and Youth Affairs (2009) 
Report of the Commission to Inquire into Child Abuse, 2009: 
implementation plan. Dublin: Stationery Office.  
Available at www.omc.gov.ie/viewdoc.asp?Docid=1173
Deaths among children and young people in state care (continued)
Parental responsibilities and drug 
treatment outcomes
A recently published analysis of data from the ROSIE study1 
aimed to establish whether having children in their care at 
intake affected the treatment outcomes of opioid users.2 
Of the 404 opiate users recruited in 2003/4 to the ROSIE 
study, 212 (53%) had children aged 17 or under (a total of 
370 children). Ninety-two of these participants had primary 
responsibility for one or more of their children. Women 
were significantly more likely than men to have primary 
responsibility for their children, 59% compared to 15.2%.  
At one-year follow-up completed questionnaires were 
obtained from 74 of the original 92 clients with children 
in their care at intake and from 213 of those not caring for 
children at intake. 
This study compares the groups at intake, and the outcomes 
at one year, rather than those at three years, based on 
evidence that ‘in general the greatest changes in outcome 
occur early in treatment, and that longer term outcomes 
do not exhibit further improvements’. As a limitation of 
the study, the author points out that a proportion of the 
participants were recruited through prisons or residential 
rehabilitation centres, and therefore could not have had 
children in their care. Additionally, participants were not 
randomly allocated to the different treatment modalities, 
which may have also affected the results.
Comparison at intake
At intake there was no significant difference in drug use 
between the two groups, with the exception of the rate of 
benzodiazepine use, which was lower among the group of 
participants with children in their care. 
Comparison at one-year follow-up
At one-year follow-up significantly fewer of the group 
with responsibility for children were using heroin, 
benzodiazepines or cannabis. This group were also using 
heroin on significantly fewer days compared to the group 
without responsibility for children. However regression 
modelling revealed that having responsibility for children 
was a significant and positive predictor for using other 
opioids. Having responsibility for children was also a positive, 
but non-significant. predictor of use of alcohol, illegal 
methadone and tobacco.
While both groups had experienced a reduction in 
psychological symptoms at one year, a greater number 
of significant reductions were experienced by the group 
who did not have responsibility for children. The analysis 
also showed that the group with responsibility for children 
experienced significantly more panic attacks.
Conclusions
The author concludes that having responsibility for children 
significantly improves the outcome of a client’s treatment for 
heroin use. The results did suggest some worrying trends, 
including the use of alcohol and other opioids among the 
group with responsibility for children, which may indicate 
that this group had been substituting other substances 
for heroin. While the effects of parental substance misuse 
on children have been studied, the ways in which having 
custodial care of one or more children may affect a client’s 
drug treatment outcomes has not been widely researched. 
The author recommends that further research in this specific 
area would improve the effectiveness of drug and alcohol 
treatment and provide the maximum benefit to both the 
parent and the child.
(Suzi Lyons)
1. The ROSIE study was Ireland’s first national, prospective, 
longitudinal drug treatment outcome study. It aimed 
to ‘evaluate the effectiveness of treatment and other 
intervention strategies for opiate use’. In 2003/04, 404 
opiate users who entered treatment were recruited, of 
whom 72% completed follow-up questionnaires one year 
and three years later. The reports on the ROSIE study are 
available at www.nacd.ie.
2. Comiskey C (2012) A 3 year national longitudinal study 
comparing drug treatment outcomes for opioid users with 
and without children in their custodial care at intake Journal 
of Substance Abuse Treatment Early online.  
www.drugsandalcohol.ie/17577
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Drugnet digest
This section contains short summaries of recent reports  
and other developments of interest. 
President opens new centre for Finglas service
The Finglas Addiction Support Team (FAST) new facility was 
officially opened by President Michael D Higgins in May 
2012. The centre works with drug users, recovered users, 
their families and the community in the Finglas area to 
provide the highest standard of addiction support. 
Set up by volunteers in 2004 in temporary accommodation, 
FAST (www.fastltd.ie) developed and expanded its service 
over the years. Supported by government funding and 
in partnership with community stakeholders, the Finglas/
Cabra LDTF and Dublin City Corporation, FAST moved to 
its impressive new premises on Wellmount Road at the end 
of 2011. Last year the centre worked with 368 individuals, 
including substance users, family and community members. 
FAST aims to dispel the stigma of addiction and to offer 
a comprehensive treatment with the best possibilities for 
long-term recovery. The treatment focuses on the mental, 
emotional and physical components of addiction. 
Speaking at the launch, Barbara Condon, general manager 
of FAST, said:
It is well established that for every person caught in 
addiction, an average of eight people consequently 
suffer. Our centre here at FAST hopes to alleviate the 
effects of addiction for all – both the substance abuser 
and family members – and to help those affected to 
build a stronger family unit. Recovering as a family allows 
healing, encourages forward movement and provides 
the recovering drug user with a support structure that is 
essential to his or her success.
FAST also announced the introduction of its Recovery 
Coach Programme, a 12-month part-time course offered in 
partnership with Dublin City University’s School of Nursing 
and Human Sciences. The only course of its kind in Ireland, it 
trains people in recovery from drug addiction to help others 
who are struggling with the process of recovery, journeying 
from detox through to aftercare. On completion of the 
course, the coaches will work on a voluntary basis with FAST. 
FAST was short-listed for Biomnis Healthcare Innovation 
Awards 2012; it has also been nominated in the Allianz 
Business to Arts Awards 2012 and has been shortlisted in 
two categories – Best Creative Staff Engagement and the 
Jim McNaughton Perpetual Award for Best Commissioning 
Practice.
Fall in numbers on waiting lists for methadone treatment
Newly published data from the HSE1 show a reduction in 
the number of people waiting for methadone treatment in 
Ireland between March 2011 and April 2012. At the end of 
April 2012 there were 187 people waiting for treatment, 
compared to 230 in March 2011. 
Most of the 48 clinics listed reported a reduction in 
waiting times and also in the number of people waiting for 
treatment; 22 centres reported no waiting list. The average 
waiting time was 0.8 months. These figures include data 
from new clinics in Kilkenny, Tullamore and Wexford that 
were set up in 2011. The clinic in Portlaoise reported the 
longest waiting list, with 24 people waiting for treatment at 
the end of April 2012, and an average waiting time of 5.7 
months. 
In a press release on publication of the new data2 Minister of 
State Róisín Shortall TD stated: ‘At a time of cut-backs, HSE 
management and frontline staff deserve credit for making 
good progress and for doing more with less. … With the 
data now available we can assess more accurately the areas 
where treatment provision needs to be boosted further and I 
will work to address these needs over the coming months.’ 
Implementing an IT system in drug and alcohol services
On 14 June 2012 Progression Routes Initiative (PRI) hosted 
a one-day seminar on information technology (IT) system 
implementation in addiction services. Merchants Quay 
Ireland hosted the event in their new premises in Dublin.
The objectives of the seminar were:
 ■ to provide an overview of IT systems which have: 
•	 capacity to support the national rehabilitation 
framework for case management and Quality 
Standards in Alcohol and Drug Services (QuADS), 
•	 proven functionality, 
•	 capacity to communicate with the National Drug 
Treatment Reporting system (NDTRS);
 ■ to explore how IT systems can support continuous 
quality improvement in addiction services;
 ■ to outline how learning networks and logical model can 
support IT implementation and reduce costs.
Fran Thompson, who works in information and 
communication technology (ICT) services in the HSE, 
provided an overview of the HSE’s development plans in 
this area. The keynote speaker, Martin McCormick, ICT 
director at Beaumont Hospital, addressed issues such as 
information storage, business continuity, data ownership, 
security, data standards and compliance with EU standards. 
Following this presentation a number of workshops explored 
how IT systems can support client work as well as staff, 
management and stakeholder requirements.
Four IT system providers, EPS, Icarus, Hanlon and eCASS, 
presented overviews of individual systems, covering: visual 
display of user interfaces; case management and other 
functionality; outcome reporting across a variety of service 
provision areas; and flexibility for adaptation and cost.
PRI has prepared a document to assist organisations in 
identifying their needs and selecting the most appropriate 
IT system provider. This document describes the systems 
currently in use and covers issues such as system 
President Higgins officially opens the new FAST centre in 
Finglas, with Barbara Condon, general manager
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functionality, data storage, security, data protection 
compliance and cost. For more information please  
contact Caroline Gardner, PRI co-ordinator,  
at caroline.gardner@aldp.ie.
Lord mayor’s commission on antisocial behaviour
A commission on antisocial behaviour established by the 
former lord mayor of Dublin, Councillor Andrew Montague, 
issued its final report in June 2012.3 Commission members 
included elected councillors and representatives of Dublin 
City Council, An Garda Síochána, the Irish Prison Service, the 
Probation Service, the Health Service Executive, the Youth 
Justice System within the Department of Justice and Equality, 
the Northside Partnership, Ballymun Drugs Task Force, the 
Ana Liffey Drug Project, Dublin City Business Improvement 
District, and an academic from the Department of Social 
Work and Policy in Trinity College Dublin.
The Commission met nine times between October 2011 and 
May 2012 and also organised a conference on the theme of 
preventing and responding to anti-social behaviour attended 
by over 300 people.4 The report and recommendations of 
the commission are presented across a range of themes, 
including the following: early intervention and prevention, 
education, discrimination and prejudice, management of 
offenders and alternatives to prison, alcohol and other drugs, 
city centre issues, and design.
Specific recommendations in relation to drugs include the 
following:
 ■ Prevention and education
•	 Deliver a national awareness campaign on the 
dangers of using alcohol, cannabis and other drugs 
during pregnancy and ensure that clear drug and 
alcohol policies are developed and implemented in 
each school.
 ■ Drug-related crime and intimidation
•	 Assist the roll-out of locally based systems of support 
which address issues related to family intimidation 
and drug debt in areas with concentrated drug 
problems and which build on the north east inner 
city pilot project.
•	 Expedite plans to identify key Garda personnel at 
district and divisional level who would be designated 
officers for families and individuals requiring support 
as a result of intimidation.
•	 Establish local and national intelligence systems to 
gather information on drug debt and liaise directly 
with the Criminal Assets Bureau.
•	 Develop a system of notification between Gardaí and 
HSE Children’s Services for the early identification of 
children who become involved in criminal activity 
(often related to drug dealing).
•	 Identify effective systems of family intervention and 
supports in this regard.
•	 Empower the gardaí to prosecute in cases where 
offenders are found to be trading prescription drugs.
Government revises poverty targets
In its update on Ireland’s national reform programme,5 
published in April 2012, the government announced 
it was abandoning the national ambition to eliminate 
‘consistent poverty’6 in Ireland, as set out in the National 
Action Plan for Social Inclusion 2007–2016.7 This decision 
was made following public consultation, engagement with 
key stakeholders, and an EU peer review on the setting of 
national poverty targets, an event which Ireland hosted in 
June 2011, and which was attended by nine member states, 
the European Commission and European stakeholders.  
The table below summarises the change in ambition.
Targets for reduction of consistent poverty, Ireland, 2007 
and 2012
2012 2016 2020
National Action Plan for Social 
Inclusion 2007–2016
2–4% 0% –
National Reform Programme 
for Ireland: 2012 Update 
– 4% 
max.
2% 
max.
Sources: Office for Social Inclusion (2007); Department of 
the Taoiseach (2012)
Explaining the change in its update, the government stated 
that between 2008 and 2010, ‘ … numbers in consistent 
poverty rose from 186,000 to 277,000, representing an 
increase of almost 50% on the 2008 figure … the rise in the 
numbers in consistent poverty over that period reflects the 
impact of the economic and fiscal crisis in Ireland, and in 
particular almost a trebling of the unemployment rate from 
4.5% in 2007 to 13.6% in 2010. There was also an effect 
from the programme of fiscal consolidation on social welfare 
adult and universal child payment rates’ (p. 15). 
The policy approach to meeting the poverty target remains 
that set out in the National Action Plan for Social Inclusion 
2007–2016, based on three inter-connecting themes of 
income support, activation and services. The government 
also asserts that improving the position of vulnerable groups, 
including children, lone parents, people with disabilities, and 
jobless households will remain critical to the achievement of 
the national poverty target. 
(Contributors: Finglas Addiction Support Team, Suzi Lyons,  
Ita Condron, Johnny Connolly and Brigid Pike)
1. Data on the waiting lists can be accessed at: http://
healthupdate.gov.ie/wp-content/uploads/2012/07/
Summary-NWL-April-12-v-March11.pdf
2. Shortall R (2012, 25 July) Minister Shortall welcomes 
significant fall in numbers waiting for opioid substitution 
treatment. Press release issued by the Department of Health 
on publication of new HSE data on methadone treatment 
waiting lists.  
www.dohc.ie/press/releases/2012/20120725.html
3. Lord Mayor’s Commission on antisocial behaviour (2012) 
Lord Mayor’s Commission on antisocial behaviour. Report. 
Dublin: Dublin City Council.
4. Video footage of presentations at the conference is available 
at http://drugs.ie/multimedia/video/conference_preventing_
and_responding_to_anti_social_behaviour
5. Department of the Taoiseach (2012) National reform 
programme for Ireland: 2012 update under the Europe 2020 
strategy. Dublin: Department of the Taoiseach.  
www.drugsandalcohol.ie/15850 
6. ‘Consistent poverty’ is defined by the Social Inclusion 
Division in the Department of Social Protection as’ the 
proportion of people, from those with an income below a 
certain threshold (less than 60% of the median income), 
who are deprived of two or more goods or services [an 
11-item index] considered essential for a basic standard of 
living’.
7. Office for Social Inclusion (2007) National action plan for 
social inclusion 2007–2016. Dublin: Stationery Office.  
www.drugsandalcohol.ie/13378
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The views of children and young people in 
state care
The Department of Children and Youth 
Affairs (DCYA) recently published a report 
detailing a consultation process with 
211 children and young people in state 
care; participants ranged in age from 8 
to 23 years.1 Fifteen consultations were 
undertaken in Cork, Dublin, Galway and 
Sligo. The young participants came from 
the following state care settings: prison and 
detention centres (43), residential disability 
care (10), foster care (58), aftercare (17), 
residential care (48), separated children 
seeking asylum (34) and young people 
under section 5 of the Child Care Act (1). 
The report provides a useful insight into 
the main issues that concern young people 
in care, the difficulties they experience in 
expressing these concerns through current 
structures and their ideas on how such 
concerns can be articulated in the future. 
Alcohol and drugs
According to the DCYA, the role played 
by alcohol and drugs in the lives of some 
of the participants was a recurring theme 
throughout the consultations. This theme 
emerged primarily from consultations with 
participants in St Patrick’s Institution (36) 
and in detention centres (7). Many of the 
participants spoke about using alcohol and/
or drugs as a means of ‘escaping’ from 
the traumatic experiences in their lives 
and few indicated any intention to stop 
using substances in the future. Many also 
recalled the adverse role that alcohol and 
drugs played in the lives of their parents, 
which had contributed largely to their being 
placed in state care in the first instance. The 
adverse experience of parental alcohol and 
drug use was also highlighted by the 58 
children aged 8–12 who were in foster care. 
Views on social workers
The majority of participants from all care 
settings expressed predominantly negative 
attitudes to and experiences of social 
workers, with older participants tending 
to be more critical than their younger 
counterparts. Overall, participants did not 
feel that social workers listened to them 
or acted in a manner that took account of 
their views. They also talked about social 
workers being constantly unavailable to 
meet with them, aside from instances when 
the young people were being disciplined 
or moving to another placement; they did 
acknowledge that social workers can be 
overburdened with caseloads of work. 
Views on care plan reviews
The vast majority of participants from 
all care settings were highly critical of 
the care plan review process and did 
not see the review as an opportunity to 
have their concerns taken seriously; they 
described the atmosphere of the review as 
intimidating due to the large number of 
officials present. 
Elements of disruption
Participants from most care settings voiced 
great concern at the constant movement 
between care placements they were forced 
to endure, with many citing this concern as 
a further destabilising factor in their lives. 
Some participants recalled having to move 
between 20 and 30 times, which meant 
constantly moving between institutions, 
families, houses and schools. This meant 
losing contact with established networks 
of friends and with siblings, which greatly 
troubled the young people. They also 
complained about the constant moving 
of staff, such as key workers and/or social 
workers, which added to their unsettling 
experiences and further instability. 
The birth family
The vast majority of participants across 
all care settings deemed it important to 
have access to their birth family, with 
participants in foster care and residential 
care especially favouring this option. Some 
participants expressed a preference to be 
consulted on this issue and not to have the 
decision to meet with their family foisted 
on them. 
Confidentiality and privacy
Many of the young participants from all 
care settings expressed concern at the 
lack of privacy they experienced, they 
were critical of the constant observation 
they were under and the level of record-
keeping that constantly documented 
their behaviours. Participants were also 
concerned at the lack of confidentiality 
they experienced citing the numerous 
adults and agencies that had access to, and 
appeared to willingly share, information 
that was specific to the young people. 
Concerns specific to young people in 
residential/detention settings
Participants from residential care and prison 
and detention settings expressed a range of 
views on their interaction with staff in these 
settings. Most young people viewed the 
role of the relationship between themselves 
and members of staff as potentially 
supportive; however, not all agreed that 
their experience of these relationships 
was positive. Where staff members were 
supportive and respectful to young people, 
this was acknowledged and appreciated 
and the young people benefited greatly 
from such experiences. On the other hand, 
there were many instances of participants 
citing negative encounters with members 
of staff, and such occurrences appeared 
to have a lasting negative impact on these 
young people. 
Concerns specific to young people in 
foster care
One of the main concerns of young people 
in foster care was the need to be treated as 
an equal in the foster family. Many felt that 
they were not treated by the foster family 
in the same way as the birth children. 
Examples of being treated differently 
included being sent to residential respite 
care while the birth children were taken on 
holiday. Participants also questioned why 
they had to be removed from the foster 
family when they turned 18, particularly 
if they felt happy and settled there. 
According to the DCYA, when with this did 
occur ‘many young people felt that they 
had merely been a transaction in a business 
arrangement’ (p.85). 
Conclusion
A general consensus emerged from the 
consultations that young people in care 
would like more meaningful consultation 
on key decisions that impact on their lives; 
few believed that the current structures of 
the care plan review process or the input 
of social workers were adequate forums 
for such meaningful consultation. The 
report recommends that both the care plan 
review system and aspects of the social 
worker service for young people in care 
be re-examined. Support mechanisms, 
including a dedicated telephone line, 
a ‘mentor’ system and counselling 
services for young people in care, are also 
recommended. These recommendations 
are grounded in the concerns and 
experiences of young people in care as 
articulated in the consultations reported 
on above. In this regard, the report 
recommends that ‘the agencies responsible 
for children in the care of the state must 
listen to the voices of the consultation 
participants and, more importantly, heed 
their recommendations’ (p.3). 
(Martin Keane)
1. Department of Children and Youth Affairs 
(2011) Listen to our voices: hearing children 
and young people living in the care of the 
state. Dublin: Stationery Office.  
www.drugsandalcohol.ie/15654
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Non-fatal overdoses and drug-related 
emergencies 2010
Data extracted from the Hospital In-Patient Enquiry (HIPE) 
scheme were analysed to determine trends in non-fatal 
overdoses discharged from Irish hospitals in 2010. There 
were 4,562 overdose cases in that year, of which 40 died 
in hospital. The 4,522 discharged cases are included in 
this analysis. The number of overdose cases increased by 
8% between 2009 and 2010, following a decrease of 13% 
between 2008 and 2009 (Figure 1).
Figure 1 Overdose cases by year, 2005–2010 
(N=28,236)
Source: Unpublished HIPE data
Characteristics of cases
Gender
In the years 2005–2010 there were more overdose cases 
among females than among males (Figure 2), with females 
accounting for 53% of all overdose cases in 2010.
Figure 2 Overdose cases by gender, 2005–2010 
(N=28,236)
Source: Unpublished HIPE data
Age group
One quarter of all overdoses between 2005 and 2010 
occurred in those aged 15–24 years, with the incidence 
of overdose decreasing with age (Figure 3). However, the 
number of under-25s was lower in both 2009 and 2010 than 
in previous years. In 2005, 40% of cases were aged under 25 
years, compared to 34% in 2010.
Figure 3 Overdose cases by age group, 2005–2010 
(N=28,236)
Source: Unpublished HIPE data
Area of residence
In 2010 there were 1,003 (22%) overdose cases among 
people resident in Dublin (city and county), 3,492 (77%) 
cases among people resident outside Dublin, and 77 cases 
recorded as having no fixed abode or being resident outside 
of Ireland. 
Drugs involved
Table 1 presents the positive findings per category of drugs 
and other substances involved in all cases of overdose in 
2010. Non-opioid analgesics were present in 34% (1,552) of 
cases. Paracetamol is included in this drug category and was 
present in 27% (1,129) of cases. Psychotropic agents were 
taken in 22% (1,000) and benzodiazepines in 24% (1,086) 
of cases. There was evidence of alcohol consumption in 12% 
(561) of cases. Cases involving alcohol are included in this 
analysis only when the alcohol was used in conjunction with 
another substance.
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Table 1 Category of drugs involved in overdose cases, 
2010 (N=4,522)
Drug category
Positive 
findings per 
drug category*
n %
Non-opioid analgesics 1552 34.3
Benzodiazepines 1086 24.0
Psychotropic agents 1000 22.1
Narcotics and hallucinogens 588 13.0
Anti-epileptic / Sedative / Anti-
Parkinson agents 563 12.5
Alcohol 561 12.4
Other chemicals and noxious 
substances 282 6.2
Cardiovascular agents 152 3.4
Systemic and haematological agents 147 3.3
Anaesthetics 118 2.6
Hormones 115 2.5
Autonomic nervous system agents 99 2.2
Systemic antibiotics 96 2.1
Gastrointestinal agents 67 1.5
Diuretics 56 1.2
Topical agents 37 0.8
Muscle and respiratory agents 36 0.8
Other gases and vapours 33 0.7
Anti-infectives / Anti-parasitics 22 0.5
Other and unspecified drugs 945 20.9
*The sum of positive findings is greater than the total 
number of cases because some cases involved more than 
one drug or substance. 
Source: Unpublished data from HIPE
Overdoses involving narcotics or hallucinogens
Narcotic or hallucinogenic drugs were involved in 13% 
(588) of overdose cases in 2010. Figure 4 shows the number 
of positive findings of drugs in this category among the 588 
cases. The sum of positive findings is greater than the total 
number of cases because some cases involved more than 
one drug from this category. Opiates were used in 80% of 
the cases, cocaine in 16% and cannabis in 8%.
Figure 4 Narcotics and hallucinogens involved in 
overdose cases, 2010 (N=588)
Source: Unpublished data from HIPE
Overdoses classified by intent
In 67% of cases the overdose was classified as intentional 
(Figure 5).
Figure 5 Overdose cases by classification, 2010  
(N= 4,491)
Source: Unpublished data from HIPE
Table 2 presents the positive findings per category of 
drugs and other substances involved in cases of intentional 
overdose in 2010. Non-opioid analgesics were involved in 
42% (1,258) of cases, benzodiazepines in 28% (832) and 
psychotropic agents in 27% (820). 
Table 2 Category of drugs involved in intentional 
overdose cases, 2010 (N=3,005)
Drug category
Positive 
findings per 
drug category*
n %
Non-opioid analgesics 1258 41.8
Benzodiazepines 832 27.7
Psychotropic 820 27.3
Anti-epileptic / Sedative / Anti-
Parkinson agents 459 15.3
Alcohol 387 12.9
Narcotics and hallucinogens 293 9.7
Cardiovascular agents 99 3.3
Systemic and haematological agents 92 3.1
Other chemicals and noxious 
substances 87 2.9
Hormones 78 2.6
Autonomic nervous system agents 68 2.3
Systemic antibiotics 68 2.3
Gastrointestinal agents 52 1.7
Anaesthetics 37 1.2
Diuretics 34 1.1
Muscle and respiratory agents 19 0.6
Anti-infectives / Anti-parasitics 16 0.5
Topical agents 11 0.4
Other gases and vapours <5 ~
Other and unspecified drugs 588 19.6
*The sum of positive findings is greater than the total 
number of cases because some cases involved more than 
one drug or substance. 
Source: Unpublished data from HIPE 
(Deirdre Mongan)
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Poisoning and clinical toxicology:  
a template for Ireland 
A recently published article reviewed poisons information 
and clinical toxicology in Ireland.1 There are two centres in 
Ireland from which information on poisons is accessible 24 
hours a day: the Poisons Information Centre of Ireland in 
Dublin, and the Regional Medicines and Poisons Information 
Service in Belfast. These centres are supported by a 
consultant toxicologist advisory service. 
The Poisons Information Centre of Ireland (01 8092566) 
offers a telephone information service for healthcare 
professionals on a 24/7, 365-days-a-year basis. Enquires are 
answered by poisons information officers between 8.00am 
and 10.00pm; calls outside of these hours are automatically 
diverted to the UK National Poisons Information Service at 
no extra charge.
The public poisons information service (01 8092166), 
also based in the Poisons Information Centre of Ireland, is 
for the general public, in particular parents and carers of 
young children. This service is available between 8.00am 
and 10.00pm daily. Outside of these hours the general 
public should contact their general practitioner or a hospital 
emergency department.
Toxbase, an online clinical toxicology database in the UK, 
has been available to Irish health professionals since 2001. 
Since then it has become the main source of information 
on poisons, with usage increasing annually. It is available 
to health professionals in emergency department and 
intensive care units; 99% of queries come from emergency 
departments. Toxbase is not available to laboratory staff.
The information most commonly accessed on Toxbase 
by health professionals in Ireland relates to paracetamol, 
diazepam, analgesics and psychoactive compounds  
(Table 1).
Table 1 The ten most frequently accessed Toxbase 
enquiries from all sources in Ireland, 2010/2011
Rank Drug Count  
(% of total)
1 Paracetamol 1431 (5.8)
2 Diazepam 679 (2.7)
3 Zopiclone 592 (2.4)
4 Ibuprofen 552 (2.2)
5 Escitalopram 436 (1.8)
6 Paracetamol/codeine compound 393 (1.6)
7 Salicylates 387 (1.6)
8 Quetiapine 376 (1.5)
9 Venlafaxine 369 (1.5)
10 Alprazolam 359 (1.4)
Source: Tormey and Moore (2012)
The authors state that data from the National Drug-Related 
Deaths Index (NDRDI) is the most accurate available 
information on toxicological deaths in Ireland.2 They 
suggest a more detailed review of the ‘Other prescription 
medication’ involved in poisoning deaths as recorded by the 
NDRDI in order to identify factors to prevent fatal overdoses 
from these medications in the future. 
In conclusion, the authors recommend the following:
 ■ provision by the HSE of a web-based, open-access 
Toxbase or equivalent as a public service;
 ■ co-location of poisons information and laboratory clinical 
toxicology;
 ■ establishment of a national clinical toxicology institute 
for Ireland;
 ■ a list of accredited medical advisors in clinical toxicology 
available for consultation in Ireland;
 ■ multidisciplinary case conferences in complex toxicology 
scenarios for coronial cases;
 ■ development of a template of standard scenarios on 
common findings in biochemical toxicology for coronial 
cases;
 ■ establishment of a national clinical toxicology referral 
out-patient service in Dublin; and
 ■ tracking changing patterns in the use of drugs of abuse 
in Ireland – clinically, biochemically and through access 
to treatment.
(Ena Lynn) 
1. Tormey WP and Moore T (2012) Poisonings and clinical 
toxicology: a template for Ireland. Irish Journal of Medical 
Science, Online First. 22 May 2012.  
www.drugsandalcohol.ie/17598
2. Health Research Board (2011) Drug-related deaths and deaths 
among drug users in Ireland: 2009 figures from the National 
Drug-Related Deaths Index. www.drugsandalcohol.i.e/16365
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First report of National Suicide Support 
and Information System 
The first report of the national Suicide Support and 
Information System (SSIS) was published in July 2012 and 
presented the results of a pilot implementation of the system 
in Co Cork between September 2008 and March 2011.1
The specific objectives of the SSIS are to: provide better 
support to the bereaved family members; identify and better 
understand the causes of suicide; identify and improve 
the response to clusters of suicide and extended suicide; 
describe the incidence of and explore patterns of suicide 
in Ireland; and identify individuals who present for medical 
treatment due to deliberate self-harm and who subsequently 
die by suicide.
The SSIS operates a two-step approach which involves: 
1. Pro-active facilitation of support for family members 
bereaved by suicide, and;
2. Obtaining information from the different sources who 
had been in contact with the deceased in the year prior 
to death or at the time of death, including coroners’ 
records, family informants and medical professionals.
The research team identified 178 cases of suicide and 12 
deaths with open verdicts in Co Cork between September 
2008 and March 2011. Initial contact with family members 
of the deceased was made by letter, explaining about the 
SSIS and offering support, with one or more follow-up 
phone calls from senior research psychologists on the team 
in 124 cases.
In relation to these 124 cases, two-fifths (40%) of close 
family members participated in bereavement support 
facilitated by the SSIS team. Just under half (48%) had 
obtained bereavement support prior to contact with the 
team. A small proportion (8%) welcomed further contact 
with a member of the team but did not want formal 
bereavement support. One in twenty (5%) family members 
did not wish to receive further contact following the initial 
invitation letter from the team.
In relation to the 190 fatalities, data on 189 cases were 
obtained from the checklists completed on the basis of the 
coroners’ records, further information was obtained from 
psychological autopsy interviews with family members for 70 
(37%) cases and from questionnaires completed by medical 
professionals for 64 (34%) cases. 
Suicide cases
The vast majority (178) of those who had died with a verdict 
of suicide were men (81%). The average age was 38 years 
and men were significantly younger at the time of death 
(36 years) than women (45 years). The majority were Irish 
(92%), single (56%), and living in a house or flat (96%). Just 
under two-fifths (38%) were unemployed, one-fifth (21%) 
were living alone and 4% were living in a supervised hostel. 
In terms of occupation, one-third (33%) had been working 
in the construction sector. 
The majority (71%) of the 178 suicide cases died by 
hanging, 11% by drowning and 10% (19) by intentional 
drug overdose. Legal drugs used in the overdose cases 
included both prescribed (17%) and non-prescribed 
(83%) medication. Illegal drugs used included cocaine and 
heroin. Eighteen per cent of the total number of cases had 
taken medication and/or drugs in combination with other 
methods, such as hanging and drowning Over one-third 
(36%) had consumed alcohol at the time of suicide. A 
minority had used other methods, including cutting or 
stabbing, carbon monoxide poisoning, firearms and self-
immolation. Forty-six per cent of cases had left a note, in the 
form of a letter, e-mail or text message.
Three-fifths (61%) of the suicide cases had a family history 
of mental disorder and the same proportion had a personal 
or family history of substance abuse. Over 39% of cases had 
either a personal experience of significant physical, sexual or 
emotional abuse or a family history of such abuse. Ten per 
cent of fatalities had a parent or sibling who had a non-
natural death, such as suicide, homicide or accident
At some time before their death, 45% of cases had engaged 
in at least one act of deliberate self-harm. Of these, 50% had 
engaged in one act, 21% in two acts and 29% in three or 
more acts. Just under half (48%) had engaged in deliberate 
self-harm in the 12 months prior to ending their lives, 24% 
less than a week before and 12% less than a day before.
Over two-thirds (68%) of the suicide cases were known to 
have experienced suicidal behaviour (fatal and/or non-fatal) 
by family members or friends at some point in their lives. Of 
these, 7% had experienced the event less than 12 months 
prior to their own death.
A psychiatric assessment was known to have taken place 
in 31% of the cases. In the majority (61%) of these cases, 
mood disorder (such as depression or bipolar) was the 
primary diagnosis, followed by anxiety disorder (13%), 
schizophrenia (9%) and alcohol dependence (9%).
In the year prior to death, 52% of the cases had abused 
alcohol and/or other drugs. Of these cases, 44% had abused 
alcohol only, 34% had abused both alcohol and other drugs 
and 16% had abused other drugs only.
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Two-thirds (65%) of the fatalities were reported to have 
experienced significant loss in the month prior to death 
(such as relationships, family members/friends, prestige 
and finances), 47% experienced a significant disruption 
to a primary relationship, 34% experienced significant 
life changes, 24% had legal trouble or difficulties with 
the Gardaí (24.2%), 23% experienced an event that 
was perceived as traumatic, and 19% experienced the 
anniversary of a death or other important loss.
In the year prior to suicide, more than half of the cases had 
had serious relationship problems for more than a year 
(53%). Loneliness over a long period of time in the year prior 
to suicide was reported for 47%. Other commonly reported 
negative events in the year prior to suicide were serious 
financial problems (44%), problems with eating (33%), 
unemployment (31%), problems bringing up children 
(28%), mental maltreatment by a partner (28%) and failure 
in achieving an important goal (20%).
The most commonly reported negative events that occurred 
earlier in the lives of people who died by suicide were 
serious relationship problems lasting for more than a year 
(66%), problems in bringing up children (44%), addiction 
to alcohol, other drugs or medication (41%), serious 
financial problems (40%), the experience of loneliness over 
a long period of time (38%) and a sudden and unexpected 
emergency (37%).
The majority (81%) of the deceased had been in contact 
with their GP or a mental health service in the year prior to 
death. Fourteen per cent had received inpatient psychiatric 
treatment in that year. Forty-one per cent had been offered 
outpatient appointments with the mental health services. 
However, nearly half (48%) had difficulties attending these 
appointments and in 65% of cases the relatives reported 
no apparent benefits from attending the recommended 
outpatient mental health services. 
Fifty-seven per cent of cases had used prescription 
medication for a mental disorder in the year prior to death. 
However, a high proportion of these (46.4%) did not 
comply with the instructions on the medication.
Suicide patterns
During the pilot phase, the SSIS identified a cluster of 19 
suicides in two small areas in Cork comprising 40,125 
inhabitants (males: 19,997, females: 20,128). The cluster 
involved adolescent and young adult males aged 14–36 
years who died by hanging between September 2008 and 
December 2010. In addition, the system identified another 
small area in Co Cork with an emerging suicide cluster. In 
this area six men, aged between 34 and 67 years, took their 
lives over a period of 13 months. The multiple sources of 
information contributing to the SSIS allowed the researchers 
to identify a number of direct and indirect relationships 
among the suicide cluster cases. 
A matched comparison between cluster and non-cluster 
suicide cases in terms of mental health and social risk 
factors was undertaken. All except three of the young 
males involved in the larger cluster had used multiple drugs 
(prescription and street drugs), often combined with alcohol, 
while this was less common among the non-cluster cases. 
Compared to the non-cluster cases, the suicide cluster cases 
were less likely to communicate their suicidal intentions and 
they were more likely to have lost a friend by suicide.
Open verdict cases
An open verdict was returned in the case of 12 deaths. 
Two-thirds (67%) were men and the average age was 60 
years. One-quarter were single. Only 8% were unemployed, 
and 42% were retired. With regard to cause of death, 
42% died by drowning, 25% died by hanging and 33% 
had used other methods. A significant minority (46%) had 
consumed alcohol at the time of death. Seventeen per cent 
had left a suicide note, e-mail or text message prior to death. 
Two-fifths (42%) had a history of deliberate self-harm. A 
relatively high proportion (67%) had a confirmed psychiatric 
diagnosis. The vast majority (88%) had a mood disorder. 
One-quarter had a history of alcohol abuse. In the year prior 
to death, 58% had used psychotropic medication.
The open verdict cases, when compared with the suicide 
cases, were more likely to be male, older, retired and have a 
history of depression or alcohol dependence. They were less 
likely to be single and unemployed. They were also more 
likely to die by drowning and less likely to die by hanging. 
The number of open verdict cases is small and comparisons 
need to be interpreted with caution. 
(Jean Long)
1. Arensman E, McAuliffe C, Corcoran P, Williamson E, O’Shea 
E and Perry IJ (2012) First report of the Suicide Support 
and Information System. Cork: National Suicide Research 
Foundation. www.drugsandalcohol.ie/18081
First SSIS report (continued)
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National Registry of Deliberate Self 
Harm annual report 2011 
The tenth annual 
report from the 
National Registry of 
Deliberate Self Harm 
was published in July 
2012.1 The report 
contains information 
relating to every 
recorded presentation 
of deliberate self-harm 
to acute hospital 
emergency 
departments in 2011, 
giving complete 
national coverage of 
cases treated.
There were 12,216 recorded presentations of deliberate 
self-harm, involving 9,834 individuals, in 2011. This implies 
that one in five (2,382, 19.5%) of the presentations were 
repeat episodes. The rate of presentations decreased from 
217/100,000 of the population in 2010 to 215/100,000 in 
2011, a 4% decrease. 
Concordant with previous reports, 48% of self-harm 
presentations in 2010 were men and 47% were aged under 
30 years. Four hundred and seventy-three (4%) self-harm 
presentations were living in homeless hostels or had no fixed 
abode, a 53% increase on the number of such presentations 
in 2010. Presentations peaked in the hours around 10pm 
and were highest on Sundays and Mondays; 31% of 
episodes occurred on these two days. There was evidence of 
alcohol consumption in 39% (4,773) of all presentations and 
this was more common among men (40%) than women 
(38%).
Drug overdose was the most common form of deliberate 
self-harm, occurring in 69% (8,409) of all such episodes 
reported in 2011. Overdose rates were higher among 
women (75%) than among men (62%). In 73% of cases the 
total number of tablets taken was known; an average of 30 
tablets was taken in these cases. The average among men 
was 32 tablets and among women 29 tablets. Forty-three 
per cent of all drug overdoses involved a minor tranquilliser 
(most commonly benzodiazepines), 26% involved 
paracetamol-containing medicines, 22% involved anti-
depressants or mood stabilisers (most commonly SSRIs) and 
10% involved a major tranquilliser. The number of deliberate 
self-harm presentations involving street drugs decreased by 
27% (to 479) in 2011 when compared to 2010 (645). Men 
(10%) were much more likely than women (3%) to self-
harm using street drugs.
The next steps, or referral outcomes for the deliberate 
overdose cases were: 46% discharged home; 33% admitted 
to an acute general hospital; 8% admitted to psychiatric 
in-patient care; a small proportion (1%) refused admission 
to hospital; and 13% discharged themselves before receiving 
referral advice.
The report provides information on what is being or can be 
done to reduce the number of self-harm cases. In January 
2012, the National Office for Suicide Prevention established 
a National Working Group on Restricting Access to Means 
with a priority on restricting access to minor tranquillisers. 
The authors recommend that this working group also review 
the implementation of the paracetamol legislation and 
prescribing patterns of SSRIs.
The authors report that alcohol continues to be one of 
the factors associated with the higher rate of self-harm 
presentations on Sundays, Mondays and public holidays, 
around the hours of midnight. These findings underline the 
need for on-going efforts to:
 ■ intensify national strategies to increase awareness of 
the risks involved in the use of alcohol starting at pre-
adolescent age;
 ■ intensify national strategies to reduce access to alcohol 
and drugs;
 ■ enhance health service capacity at specific times and 
increase awareness of the negative effects of alcohol use 
such as increased depressive feelings and reduced self-
control;
 ■ arrange active collaboration between the mental health 
services and addiction treatment services in the best 
interest of patients who present with dual diagnosis 
(psychiatric disorder and alcohol/drug abuse).
The authors report that there was variation in the next 
care recommended to deliberate self-harm patients, and 
in the proportion of patients who left hospital before a 
recommendation, from 8% in the Southern Hospitals Group 
to 24% in the Dublin North East Hospitals Group.  
In 2012, a sub-group of the National Mental Health Clinical 
Programme Steering Group produced National guidelines 
for the assessment and management of patients presenting 
to Irish emergency departments following self-harm. The 
authors recommend ‘that these guidelines be implemented 
nationally as a matter of priority’. 
(Jean Long)
1. National Suicide Research Foundation (2012)  
National Registry of Deliberate Self Harm annual report 2011. 
Cork: National Suicide Research Foundation.  
www.drugsandalcohol.ie/18082
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Fifth ESPAD survey report published 
The European School 
Survey Project on 
Alcohol and Other 
Drugs (ESPAD) has 
conducted surveys of 
school-going children 
every four years since 
1995, using a 
standardised method 
and a common 
questionnaire (see 
www.espad.org).  
The fifth survey was 
conducted in 36 
European countries 
during 2010/111 and 
collected information 
on alcohol, tobacco 
and illicit drug use 
among 15–16-year-old 
students. 
The rationale for the ESPAD surveys is that school students 
are easily accessible and are at an age when onset of 
substance use is likely to occur. Early school leavers, a group 
known to be vulnerable to alcohol and drug use, are not 
represented in this survey, so the results do not indicate the 
extent of alcohol and other drug use among all 15–16-year-
old children. ESPAD survey information is valuable in 
planning prevention initiatives. 
This article concentrates on the findings from the survey 
conducted in Ireland in 2010/2011, when 2,207 students 
from 72 randomly selected schools completed valid 
questionnaires. Fewer schools and students participated in 
2010 than in 2007 or 2003. 
Four-fifths of the students (80% boys and 81% girls) 
reported that they had consumed alcohol at some point 
in their life, and 73% (72% of boys and 73% of girls) had 
drunk alcohol in the year prior to the survey. Half (48% boys 
and 52% girls) had drunk alcohol in the 30 days prior to the 
survey, a decrease of six percentage points since the 2007 
survey (56%). Two-fifths (40%) reported having had five or 
more drinks on a single occasion in the month prior to the 
survey. Almost one-quarter (23%) reported that they had 
had one or more episodes of drunkenness in the 30 days 
prior to the survey, a decrease of three percentage points 
since the 2007 survey (26%). Nine per cent of the girls and 
13% of the boys had their first episode of drunkenness at 
or before the age of 13 years. The 2011 European average 
for alcohol consumption in the last 30 days was 57% (7 
percentage points higher than Ireland), while the European 
average for drunkenness in the last 30 days was 17% (6 
percentage points lower than Ireland). 
Beer (40%), spirits (35%) and cider (33%) were the most 
common types of alcohol drunk in the month prior to the 
survey. Respondents reported drinking an average of 6.7 
centilitres of alcohol on the last alcohol-drinking day prior 
to the survey, which places Ireland (and the UK) joint fifth 
highest. Those who drank alcohol at some point in their life 
were asked to rate their level of intoxication during the last 
alcohol drinking day on a scale of one to ten; the average 
rate for Irish students was 3.8, which places Ireland third 
highest after the UK and the Faroe Islands. 
Eighty-four per cent of the students reported that alcohol 
was easy or fairly easy to acquire in Ireland. Over one-quarter 
(26%) had bought alcohol for their own consumption in an 
off-trade outlet in the 30 days prior to the survey; 37% had 
done so in an on-trade outlet. Sixty five per cent reported 
that they were likely to experience positive consequences of 
alcohol consumption, while 35% were likely to experience 
negative consequences. Some of the negative consequences 
reported were: getting into trouble with the police (22%), 
not being able to stop drinking (20%), and doing something 
they regretted (48%). Ten per cent of boys and six per cent 
of girls had experienced delinquency problems as a result of 
their alcohol use in the year prior to the survey. Delinquency 
problems included being involved in a physical fight (16% 
boys and 7% girls), being a victim of robbery or theft (4% of 
boys and 3% of girls), and being in trouble with the police 
(11% of boys and 8% of girls). 
The lifetime use of alcohol decreased by 10 percentage 
points in 15 years, falling from 91% in 1995 to 81% in 2011, 
and alcohol use in the month prior to the survey decreased 
by 19 percentage points, from 69% in 1995 to 50% in 
2011. The proportion reporting having had five or more 
drinks on one occasion during the last 30 days decreased 
by only four percentage points, from 23% in 1995 to 19% 
in 2011. The consumption of five or more drinks in the one 
sitting is an indicator of the harmful use of alcohol. 
Over two-fifths (43%) of the students (42% of boys and 
45% of girls) reported that they had smoked cigarettes at 
some point in their life, and 21% (19% of boys and 23% 
of girls) had smoked cigarettes in the 30 days prior to the 
survey. Over one-fifth had their first cigarette at or before 
the age of 13 years. Five per cent were smoking daily at 
or before the age of 13 years. The 2011 European average 
for smoking cigarettes in the last 30 days was 28% (7 
percentage points higher than Ireland), while the European 
average for smoking cigarettes daily at age 13 or under was 
6% (one percentage point higher than Ireland). Three-
quarters reported that cigarettes were easy or fairly easy to 
acquire in Ireland. Over one-fifth thought that people who 
smoked cigarettes occasionally were at great risk of harming 
themselves; 67% thought that smoking one or more packs a 
day constituted a great risk. 
The reduction in cigarette use is larger than the reduction in 
alcohol use, and alcohol is easier to acquire than cigarettes. 
The rate of lifetime use of cigarettes decreased by 31 
percentage points, from 74% in 1995 to 43% in 2011, 
and use in the month prior to the survey decreased by 20 
percentage points, from 41% in 1995 to 21% in 2011. The 
proportion who reported smoking cigarettes on a daily basis 
by age 13 years decreased by 13 percentage points, from 
18% in 1995 to 5% in 2011.
The Irish data show a fall of 3 percentage points in the rate 
of lifetime use of any illicit drug between 2007 (22%) and 
2011 (19 (Table 1). Boys (23%) were more likely than girls 
(15%) to use illicit drugs at some point in their life. As the 
majority of 15–16-year-olds who have tried any illicit drug 
have used cannabis (marijuana or hashish), the decrease in 
illicit drug use may be explained by the fall in the number 
of students who had tried cannabis at some point in their 
lives, from 20% in 2007 to 18% in 2011 (just above the 
European average of 17%). Boys (22%) were more likely 
than girls (15%) to use cannabis at some point in their life. 
Fourteen per cent of respondents had used cannabis in the 
year prior to the survey (above the European average of 
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12%). Only two per cent had used ecstasy at some point in 
their life and the proportion was the same in the year prior 
to the survey, indicating recent introduction to the use of 
this drug. In the case of cocaine powder, 3% had used it 
in their lifetime, just above the European average of 2%. 
Nine per cent of respondents reported that they had taken 
prescribed tranquillisers or sedatives at some point in their 
lives, and a further three per cent had taken them without 
a prescription. One in twenty had taken alcohol with pills 
‘in order to get high’. Lifetime use of solvents/inhalants 
decreased considerably, from 15% in 2007 to 9% in 2011, 
and the rate is now the same as the European average (9%). 
Forty per cent of the students reported that cannabis was 
easy or fairly easy to acquire in Ireland, while lower but 
considerable proportions reported that amphetamines 
(14%), ecstasy (21%) and sedatives (17%) were easy or fairly 
easy to acquire. Alcohol and cigarettes are easier to acquire 
than illicit drugs. 
Table 1 Respondents in Ireland who reported lifetime use of drugs in the ESPAD surveys of 1995, 1999, 2003,  
2007 and 2011
Lifetime use
1995 
%
1999 
%
2003 
%
2007 
%
2011 
%
Any illicit drug* 37 32 40 22 19
Cannabis 37 32 39 20 18
Inhalants (solvents) n.a. 22 18 15 9
Ecstasy 9 5 5 4 2
Cocaine powder 2 2 3 4 3
Amphetamines 3 3 1 3 2
Prescribed tranquilisers or sedatives n.a. 11 10 10 9
Non-prescribed tranquilisers or sedatives 7 5 2 3 3
* includes amphetamines, cannabis, cocaine, crack, ecstasy, heroin and LSD or other hallucinogens  
n.a. = not available 
(Jean Long)
1. Hibell B, Guttormsson U, Ahlström S, Balakireva O, Bjarnason T, Kokkevi A and Kraus L (2012) The 2011 ESPAD report: substance 
use among students in 36 European countries. Stockholm: The Swedish Council for Information on Alcohol and Other Drugs (CAN) 
and the Pompidou Group of the Council of Europe. www.drugsandalcoohol.ie/17644
ESPAD survey (continued)
Drug use among the general population, 
by regional drugs task force area 
On 19 June a new bulletin was published outlining drug 
prevalence data by regional drugs task force (RDTF) area 
based on findings from the 2010/2011 National Advisory 
Committee on Drug’s general population survey on drug 
use.1 This is the third of these surveys, previously done 
in 2002/3 and 2006/7. Drug prevalence surveys of the 
general population are important in that they can shed 
light on the patterns of drug use, both demographically 
and geographically and, when repeated, can track changes 
over time. The Irish survey followed best practice guidelines 
recommended by the European Monitoring Centre for 
Drugs and Drug Addiction (EMCDDA). The commentary 
in this article concentrates on the prevalence of drug use 
in the year prior to the survey (described as ‘recent’ use) as 
this is the most useful measure for policy makers and service 
planners. 
 ■ Recent (or last-year) illicit drug use among the 
15–64-year-old population stabilised or decreased 
marginally in most RDTF areas between 2006/7 and 
2010/11, with no area showing a significant increase 
(Table 1). As expected, recent use is higher among men 
than women and higher among those aged 15–34 years 
than among their older counterparts.
 ■ Cannabis was the most commonly reported illegal drug 
used in each of the RDTF areas, with rates of recent 
use ranging between 2.8% in the North West and 
9.4% in North Dublin (Table 2 and Figure 1). Rates 
have stabilised or fallen in six RDTF areas (though not 
statistically significantly) and increased significantly in 
one area, the Western RDTF.
 ■ Recent ecstasy use decreased somewhat in all RDTF 
areas (significantly so in the East Coast area only), with 
proportions ranging between 0% in the North West 
and 1.3% in North Dublin. (Table 3). Anecdotal reports 
of seizures and adverse events through early warning 
reports indicate that the ecstasy use increased in late 
2011 and 2012.
 ■ Cocaine was the second most common illicit drug used 
in the year prior to the survey (Table 4).  Its use was 
highest in the North Dublin, South West and East Coast 
RDTF areas. Recent cocaine use stabilised or decreased 
somewhat in nine areas and increased significantly in 
only one, the South West (SW Dublin, W Wicklow and 
Kildare).
 ■ Recent use of new psychoactive substances was reported 
in all RDTF areas. The rate of use was highest in the East 
Coast (7.7%) and lowest in the North West (1.5%). It 
has been suggested that new psychoactive substances 
may take the place of other stimulants, which may 
account for the marginal decrease in cocaine and 
ecstasy use since 2006/7.2 Anecdotally, the use of new 
psychoactive substances appears to have decreased, 
which is evidenced by a reduction in the number 
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of adverse events reported since the introduction of 
relevant legislation. 
 ■ Recent use of sedatives and tranquillisers (such as 
benzodiazepines and zopiclone, both prescribed and 
non-prescribed) has increased significantly in three RDTF 
areas (North Dublin, South West and North Eastern) and 
decreased significantly in the North West. Sedatives and 
tranquilisers are among the four most common drugs 
used in all RDTF areas (Figure 1). 
 ■ The definition of the category ‘other opiates’ was 
broadened in successive surveys, to be consistent 
with the definition used in Northern Ireland, and to 
include substances that contain codeine (an opiate). 
Consequently, data from the 2010/11 survey on recent 
use of ‘other opiates’ is not comparable with data for 
that category in previous surveys  In 2010/11 the rate 
of recent use of other opiates is high in all RDTF areas, 
ranging from 19.1% in the North West to  37.5% in the 
Western area (Figure 1). 
(Jean Long and Justine Horgan) 
1. National Advisory Committee on Drugs and Public Health 
Information and Research Branch (2012) Drug use in Ireland 
and Northern Ireland. Drug Prevalence Survey 2010/11: 
Regional Drug Task Force (Ireland) and Health and  
Social Care Trust (Northern Ireland) Results. Bulletin 2.  
Dublin: National Advisory Committee on Drugs.  
www.drugsandalcohol.ie/17753
2. Horgan J (2011) Drug use in Ireland and Northern Ireland. First 
results from the 2010/11 Drug Prevalence Survey. PowerPoint 
presentation of findings on publication of Bulletin 1 of the 
survey. Dublin: National Advisory Committee on Drugs. 
www.drugsandalcohol.ie/16450
Drug use among the general population, by RDTF area (continued)
Table 1 Proportion of respondents aged 15-64 years who reported lifetime and last-year use of illegal drugs,  
by regional drugs task force area of residence
Percentage that used any illegal drugs*
RDTF area of residence Ever in lifetime Year prior to survey
2002/3 2006/7 2010/11 2002/3 2006/7 2010/11
Ireland 18.5 24.0 27.2 5.6 7.2 7.0
East Coast (of Dublin, and East Wicklow) 25.9 38.4 38.0 6.3 12.4 9.2
North Dublin City & County 29.5 32.2 34.6 8.4 12.8 10.5
South West (of Dublin, West Wicklow, and Kildare) 24.0 25.6 36.3 7.5 7.4 11.1
South East 18.5 25.5 25.3 6.9 7.9 5.9
North Eastern 18.9 22.1 23.9 6.4 5.4 4.0
Midland 11.0 19.6 19.1 2.8 4.4 4.8
Mid West 12.0 18.0 18.7 3.2 5.8 5.1
Southern 12.1 16.3 24.2 4.7 4.9 6.1
Western 12.5 20.4 23.8 2.9 4.2 5.1
North West 10.6 14.6 16.6 2.6 3.0 2.8
* Illegal drugs in this context are amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, 
poppers and solvents.
Data source: National Advisory Committee on Drugs and Public Health Information and Research Branch (2012)
Table 2 Proportion of respondents aged 15-64 years who reported lifetime and last-year use of cannabis,  
by regional drugs task force area of residence
Percentage that used cannabis
RDTF area of residence Ever in lifetime Year prior to survey
2002/3 2006/7 2010/11 2002/3 2006/7 2010/11
Ireland 17.3 21.9 25.3 5.1 6.3 6.0
East Coast (of Dublin, and East Wicklow) 24.5 35.9 36.2 6.1 11.3 7.7
North Dublin City & County 26.9 28.8 30.2 7.7 11.9 9.4
South West (of Dublin, West Wicklow, and Kildare) 23.2 24.0 33.4 7.3 6.7 8.7
South East 16.8 23.3 24.2 5.8 5.1 4.1
North Eastern 17.8 19.2 20.5 5.2 4.3 3.3
Midland 10.7 17.0 17.4 2.8 4.1 4.3
Mid West 10.9 17.0 17.9 3.0 4.7 5.0
Southern 11.6 15.0 23.3 4.4 4.6 5.5
Western 12.0 18.4 23.0 2.0 3.9 4.9
North West 9.3 13.0 16.1 2.2 3.0 2.8
Data source: National Advisory Committee on Drugs and Public Health Information and Research Branch (2012)
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Table 3 Proportion of respondents aged 15-64 years who reported lifetime and last-year use of ecstasy,  
by regional drugs task force area of residence
Percentage that used ecstasy
RDTF area of residence Ever in lifetime Year prior to survey
2002/3 2006/7 2010/11 2002/3 2006/7 2010/11
Ireland 3.7 5.4 6.9 1.1 1.2 0.5
East Coast (of Dublin, and East Wicklow) 5.4 7.6 9.4 2.5 2.3 0.3U
North Dublin City & County 6.5 11.2 11.3 1.6 2.9 1.3
South West (of Dublin, West Wicklow, and Kildare) 5.9 4.1 10.4 1.3 0.5 0.7
South East 4.3 6.5 6.4 1.3 1.9 0.6
North Eastern 2.6 5.2 4.9 0.5 0.8 0.1
Midland 2.0 5.8 3.0 0.9 0.9 0.0
Mid West 1.7 2.9 4.9 0.6 0.8 0.4
Southern 2.8 3.5 5.7 0.9 0.6 0.4
Western 1.8 3.9 3.7 0.3 0.7 0.4
North West 0.3 2.3 3.6 0.0 0.3 0.0
Data source: National Advisory Committee on Drugs and Public Health Information and Research Branch (2012)
Figure 1 Last-year prevalence among the general population of the most commonly used legal and illegal drugs 
(excluding alcohol), by regional drugs task force area, 2010/11
Data source: National Advisory Committee on Drugs and Public Health Information and Research Branch (2012)
Drug use among the general population, by RDTF area (continued)
North West RDTF
Other opiates 19.1%
Sedatives (mainly 
benzodiazepines) 4.0%
Anti-depressants 3.1% 
Cannabis 2.8%
North Eastern RDTF
Other opiates 24.9%
Sedatives (mainly 
benzodiazepines) 9.6%
Anti-depressants 7.3% 
Cannabis 3.3%
Western RDTF
Other opiates 37.5%
Sedatives (mainly 
benzodiazepines) 5.2%
Cannabis 4.9%
Anti-depressants 3.3% Midland RDTF
Other opiates 25.4%
Sedatives (mainly 
benzodiazepines) 5.4%
Anti-depressants 4.5% 
Cannabis 4.3%
North Dublin City & County RDTF
Other opiates 27.9%
Cannabis 9.4%
Sedatives (mainly benzodiazepines) 7.7%
Anti-depressants 2.9%
South West RDTF
Other opiates 25.9%
Cannabis 8.7%
Sedatives (mainly 
benzodiazepines) 8.9%
Anti-depressants 6.6%
East Coast RDTF
Other opiates 25.7%
Cannabis 7.7%
New psychoactive substances 6.1%
Sedatives (mainly benzodiazepines) 5.8%
Mid West RDTF
Other opiates 21.4%
Sedatives (mainly 
benzodiazepines) 5.9%
Cannabis 5.0%
Anti-depressants 4.5%
Southern RDTF
Other opiates 35.2%
Cannabis 5.5%
Anti-depressants 5.3%
Sedatives (mainly 
benzodiazepines) 4.9%
South East RDTF
Other opiates 27.8%
Sedatives (mainly 
benzodiazepines) 5.4%
Cannabis 4.1%
Anti-depressants 4.0%
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Table 4 Proportion of respondents aged 15-64 years who reported lifetime and last-year use of cocaine,  
by regional drugs task force area of residence
Percentage that used cocaine*
RDTF area of residence Ever in lifetime In year prior to survey
2002/3 2006/7 2010/11 2002/3 2006/7 2010/11
Ireland 3.0 5.3 6.8 1.1 1.7 1.5
East Coast (of Dublin, and East Wicklow) 6.3 9.1 10.1 2.3 3.1 2.7
North Dublin City & County 5.2 11.0 11.9 1.7 3.3 2.6
South West (of Dublin, West Wicklow, and Kildare) 5.0 3.8 9.6 1.5 0.8 2.9
South East 2.5 6.7 5.5 1.7 2.4 1.5
North Eastern 1.2 5.4 5.3 0.0 1.4 0.5
Midland 1.3 4.4 4.0 0.3 1.7 0.7
Mid West 1.1 2.9 4.5 0.7 1.0 0.4
Southern 1.9 3.1 4.9 0.7 1.1 1.0
Western 1.7 3.1 5.5 0.7 1.5 0.8
North West 0.0 1.6 2.7 0.0 0.3 0.3
* Includes cocaine powder and crack cocaine.
Data source: National Advisory Committee on Drugs and Public Health Information and Research Branch (2012)
Drug use among the general population, by RDTF area (continued)
Unmet needs and benzodiazepine 
misuse among people in treatment 
Many problem opiate users in treatment also misuse other 
substances. This presents a challenge to addiction services as 
often one single service cannot address the complex needs 
of such clients. A study carried out in the Drug Treatment 
Centre Board examined clients’ perceptions of unmet needs 
and the association between misuse of non-prescribed 
benzodiazepines and extent of unmet needs.1 
The authors used the Camberwell Assessment of Need Short 
Appraisal Schedule – Patient-rated version (CANSAS-P) as the 
measurement tool for this study.2 
CANSAS-P provides scores based on the client’s ratings of 22 
items in terms of total needs, unmet needs and met needs. 
Unmet needs can be used as a predictor of perceived quality 
of care. The authors believe this is the first study to use 
this tool to assess unmet needs among clients of addiction 
services. 
Clients who were opiate dependent and receiving 
methadone for at least three months were eligible to 
participate in the study. Clients with acute or end-stage 
medical problems were excluded. Over half (107, 56%) 
of 191 eligible clients took part. There were no statistically 
significant differences between the socio-demographic 
characteristics of those who took part and those who did 
not. 
Of the 107 participants, 52 (49%) reported using non-
prescribed benzodiazepines in the previous month. Of 
these, only one reported both oral and intravenous use. 
The mean number of days on which benzodiazepines were 
used was 14, and 90% had benzodiazepine-positive urine 
samples in the previous month. The group who misused 
benzodiazepines had statistically more frequent use of both 
cocaine (mean 2.4 days versus mean 1.6 days) and heroin 
(mean 12.3 days versus mean 5.3 days) compared to the 
group who did not misuse benzodiazepines. Table 1 shows 
the mean number of met and unmet needs in both groups.
The highest proportions of unmet needs related to the 
following items in the assessment tool: substance misuse 
treatment, daytime activities, social company, money 
budgeting and benefits, psychological distress, and physical 
health. There were statistical differences between the 
two groups in relation to substance misuse and daytime 
activities. Needs that were generally rated as met included 
accommodation, food, telephone access, self-care, childcare 
and transportation.
Multivariate linear regression showed that a higher 
number of days of benzodiazepine misuse was significantly 
associated with a higher unmet needs rating. The authors 
stress that this was a study of needs assessment and that it 
‘does not propose that fulfilling unmet needs will necessarily 
alter benzodiazepine misuse among opioid users’. They 
recommend a more formal and active assessment of the 
needs of clients on methadone treatment and rapid access 
to evidence-based treatment for benzodiazepine misuse.
(Suzi Lyons)
1. Apantaku-Olajide T, Ducray K, Byrne P and Smyth PB 
(2012) Perception of unmet needs and association with 
benzodiazepine misuse among patients on a methadone 
maintenance treatment programme. The Psychiatrist, 36(5): 
169–174. www.drugsandalcohol.ie/17746
2. The CANSAS-P tool was chosen as it has good reliability and 
validity for measuring unmet needs and has been positively 
evaluated by clients. Ratings of unmet needs by clients have 
been found to be more reliable than those by staff. 
Table 1 Mean number of client needs, met and unmet, and association with benzodiazepine use 
Benzodiazepine misuse (n = 52) No benzodiazepine misuse (n = 55)
Mean number of needs 7.8 6.4 p = 0.02
Mean number of met needs 1.8 1.6 p = 0.53
Mean number of unmet needs 5.9 4.7 p = 0.02
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Trends in alcohol and drug admissions 
to psychiatric facilities
Activities of Irish psychiatric units and hospitals 2010, the 
annual report published by the Mental Health Information 
Systems Unit of the Health Research Board, shows that the 
total number of admissions to inpatient care has continued 
to fall.1 
In 2010, 1,798 cases were admitted to psychiatric facilities 
with an alcohol disorder, of whom 637 were treated for 
the first time. Figure 1 presents the rates of first admission 
between 1990 and 2010 of cases with a diagnosis of alcohol 
disorder.2 The trend of recent years has continued, with 
again a reduction in the rates of admission for alcohol 
disorders in 2010. Thirty nine per cent of cases hospitalised 
for an alcohol disorder stayed just under one week, while 
22% were hospitalised for between one and three months. 
In 2010, 966 cases were admitted to psychiatric facilities 
with a drug disorder, of whom 412 were treated for the first 
time. Since 2006 there has been a continuous increase in 
the rate of first admission of cases with a diagnosis of a drug 
disorder. The report does not present data on drug use and 
psychiatric co-morbidity, so it is not possible to determine 
whether or not these admissions were appropriate. Figure 2 
presents the rates of first admission between 1990 and 2010 
of cases with a diagnosis of drug disorder. 
Other notable statistics on first admissions for a drug 
disorder in 2010 include:
 ■ The majority were to psychiatric units in general 
hospitals (259, 63%), followed by admissions to 
psychiatric hospitals (102, 25%) and to private hospitals 
(51, 12%). 
 ■  6% were involuntary admissions.
 ■ The rate was higher for men (14.2 per 100,000) than for 
women (5.2 per 100,000).
The majority of cases hospitalised for a drug disorder stayed 
just under one week (54%), while most were discharged 
within three months.
(Suzi Lyons)
1. Daly A and Walsh D (2011) Activities of Irish psychiatric units 
and hospitals 2010: main findings. HRB Statistics Series 15. 
Dublin: Health Research Board.  
www.drugsandalcohol.ie/16329
2. Annual reports from the National Psychiatric In-patient 
Reporting System (NPIRS) for the years 1990 to 2010  
are available on the Health Research Board website at  
www.hrb.ie/publications/mental-health
Figure 1 Rates of psychiatric first admission of cases with a diagnosis of alcohol disorder (using the ICD-10 three-
character categories) per 100,000 of the population in Ireland, NPIRS 1990–20102
Figure 2 Rates of psychiatric first admission of cases with a diagnosis of drug disorder (using the ICD-10 three-
character categories) per 100,000 of the population in Ireland, NPIRS 1990–2010
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Drugs and crime data 2012
This article looks at trends in reported drug offences 
and drug seizures for various periods between 2003 and 
2011. It should be noted that drug offence and seizure 
data are primarily a reflection of law enforcement activity. 
Consequently, they are affected in any given period by 
such factors as law enforcement resources, strategies and 
priorities, and by the vulnerability of drug users and drug 
traffickers to law enforcement activities. Having said that, 
drug seizures are seen as indirect indicators of the supply 
and availability of drugs.
Figures 1 and 2 show trends in proceedings for drug 
offences from 2004 to 2010. As can be seen from Figure 
1, criminal proceedings for the possession of drugs for 
personal use (simple possession) decreased in 2009 for the 
first time since 2004. This decrease continued throughout 
2010. Possession offences accounted for 69.1% of total drug 
offences in 2010. Proceedings for drug supply increased 
slightly, from 2,824 in 2009 to 2,881 in 2010.
Figure 1 Trends in relevant legal proceedings for 
total drug offences, drug possession for 
personal use and for supply, 2004–2010
Source: Central Statistics Office (2012) unpublished data
Obstruction offences often involve an alleged offender 
resisting a drug search or an arrest or attempting to dispose 
of drugs to evade detection. Such offences continue to 
account for the largest number of prosecutions, although 
the number declined slightly in 2010 following an increase 
in 2009. A similar trend can be observed in relation to 
the offence of being in possession of forged/altered 
prescriptions.
Of particular significance is the large increase in the offence 
of cultivating/manufacturing controlled drugs. Proceedings 
for this offence have continued to increase since 2005, when 
there were 29 related proceedings, reaching 167 in 2009 
and almost doubling to 301 in 2010. It is unclear whether 
this increase reflects a genuine growth in the commission of 
such offences or whether it reflects a sustained concentration 
of law enforcement on their detection. For example, in 
2010, the Garda Síochána conducted Operation Nitrogen, a 
nationwide investigation by district and divisional drug units 
into cannabis cultivation sites.1 This specific focus may have 
had an impact on the data presented here.
Drug driving offences
Figure 3 shows the trend in prosecutions for driving under 
the influence of drugs (DUID) between 2003 and 2010. 
Between 2006 and 2009 the number of prosecutions for 
DUID increased from 74 to 703, an increase of more than 
900%. It is unclear why this increase has occurred. It could 
be due to an increase in the incidence of DUID or, the more 
likely possibility, to an increase in targeted police activity in 
this area. In 2010 the number of such offences decreased 
significantly, to 456 offences.
Figure 2 Trends in relevant legal proceedings for 
selected drug offences, 2004–2010
Source: Central Statistics Office (2012)
Figure 3 Trend in relevant legal proceedings for 
driving in charge of a vehicle while under 
the influence of drugs, 2005–2010
Source: Central Statistics Office (2012)  
Interactive tables online
Drug offence data can assist us in understanding aspects of 
the operation of the illicit drug market in Ireland.2 Data on 
drug offence prosecutions by Garda division are a possible 
indicator of national drug distribution patterns. While these 
data primarily reflect law enforcement activities and the 
relative ease of detection of different drugs, when compared 
with other sources, such as drug treatment data, for 
example, they can show us trends in market developments 
throughout the State. Such data can also indicate trafficking 
patterns by showing whether there is a concentration of 
prosecutions along specific routes. Figures 4 and 5 show 
trends in relevant legal proceedings for possession of drugs 
by Garda region. It should be noted that possession includes 
possession for personal use and possession for the purpose 
of supply. It is not possible to distinguish between these two 
offences in the data reported by Garda region. However, 
as shown in Figure 1 above, it is generally the case that in 
65%–75% of all possession cases the drugs are deemed to 
be for personal use.
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As shown in Figure 4, an upward trend since 2003 in 
relevant legal proceedings for possession (including for 
personal use and for supply) continued until 2008, and then 
decreased between 2008 and 2010. The majority of such 
proceedings were in the Dublin Metropolitan Region (DMR). 
The number of such offences in the DMR increased steadily 
from 1,433 in 2003 to 5,279 in 2008. The number then 
decreased to 3,986 in 2010, just below the level reported for 
2007.
Figure 4 Trends in relevant legal proceedings for 
possession of drugs for personal use and for 
sale or supply, nationally and in the Dublin 
Metropolitan Region, 2003–2010
Source: Central Statistics Office (2012) unpublished data
Figure 5 shows trends in supply offences by Garda region, 
excluding Dublin. Trends in supply offences have increased 
in all regions since 2003. This reflects the reality that 
drug markets are no longer primarily a Dublin-based 
phenomenon.. Following this general increase throughout 
the country since 2003, relevant legal proceedings for drug 
possession (for personal use and supply) decreased in all 
regions between 2008 and 2010, with the exception of the 
Northern Region where there was a slight increase in 2009 
on the previous year, followed by a decrease in 2010.
Figure 5 Trends in relevant legal proceedings for 
possession of drugs for personal use and 
for sale or supply, by region, excluding the 
DMR, 2003–2010
Source: Central Statistics Office (2012) unpublished data
Drug seizures 
Cannabis seizures account for the largest proportion of all 
drugs seized. Figure 6 shows trends in cannabis-related 
seizures and total seizures between 2005 and 2011. The 
total number of drug seizures increased to a peak of 10,444 
between 2005 and 2007. Between 2007 and 2010, the 
number almost halved, to a total of 5,477 in 2010. This 
decrease in total seizures since 2007 can be explained 
primarily by the significant decrease in the number of 
seizures of cannabis-type substances. It should be noted that 
not all drugs seized by law enforcement are necessarily 
analysed by the Forensic Science Laboratory, and are 
therefore not officially reported by the CSO. However, it is 
difficult to know if the reduction in cannabis-related seizures 
reflects a decline in cannabis use or a reduction in law 
enforcement activity. It may also be partly explained by a 
change in the nature of cannabis use, with people moving 
from resin use to the use of more potent forms of cannabis. 
For example, as shown in Figure 7, when we look more 
closely at cannabis-related seizures it can be seen that 
although seizures of cannabis resin decreased between 2009 
and 2011, there has been a steady increase in seizures of 
cannabis plants since 2006, while herbal cannabis seizures 
almost doubled between 2009 and 2011, increasing from 
981 to 1,833.
Figure 6 Trends in the total number of drug seizures 
and cannabis seizures, 2005–2011
Source: Central Statistics Office (2008, 2009, 2010, 2011, 
2012)
Figure 7 Trends in the total number of cannabis 
seizures by cannabis type, 2005–2011
Source: Central Statistics Office (2008, 2009, 2010,2011, 
2012)
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Drugs and crime data 2012 (continued)
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The reduction in the total number of reported seizures 
since 2007 shown in Figure 6 may also be a consequence 
of the reduction in the number of seizures of other drugs 
since 2007. Figure 8 shows trends in seizures for a selection 
of drugs, excluding cannabis, between 2003 and 2011. 
There has been a significant decline in seizures of cocaine 
and heroin since 2007. Seizures of ecstasy-type substances 
also decreased significantly between 2007 and 2010, but 
increased by more than 900% in 2011. 
(Johnny Connolly)
1. An Garda Síochána (2012) Annual report 2011. Dublin: An 
Garda Síochána.
2. Connolly J (2005) The illicit drug market in Ireland. HRB 
Overview Series 2. Dublin: Health Research Board.  
www.drugsandalcohol.ie/6018
Figure 8 Trends in the number of seizures of selected 
drugs, excluding cannabis, 2003–2011
Source: Central Statistics Office (2012)
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Drugs in prisons
The Inspector of Prisons, Judge Michael Reilly, published a 
report on Limerick Prison in November 2011.1 The report 
notes that ‘most prisoners have addiction problems’ (p.27). 
In relation to the availability of drugs in the prison, the 
report states:
… all yards are covered by nets, a dedicated search 
procedure (with appropriate protocols) operates for 
all persons entering the prison, a dedicated drug dog 
is on duty, mandatory drug testing of prisoners is the 
norm and random targeted searches are carried out. The 
Operational Support Group (OSG) is the dedicated unit 
responsible for such initiatives. These measures have had 
the combined effect of reducing the amount of drugs 
and contraband entering the prison. (p.26)
The Inspector’s report is, however, also highly critical about 
overcrowding and the presence of ‘gangs’ in the prison. 
It also reiterates the need for the establishment of a drug-
free unit in the prison, stating that ‘there are a number of 
prisoners, not only in Limerick prison but in all prisons in 
the Irish prison system, who wish to either remain drug free 
or try to become drug free’ and that Limerick, ‘in common 
with all closed prisons, should have a drug free support unit’ 
(p.38). In a follow-up report, published in March 2012, the 
Inspector comments further in relation to a drug-free unit: 
‘Because of the present overcrowding in Limerick Prison it 
has not been possible to identify a section of the prison that 
could be dedicated as a drug free support unit’2 (p.8). 
Prison visiting committees are appointed to each prison 
under the Prisons (Visiting Committees) Act 1925 and the 
Prison (Visiting Committees) Order 1925. These committees 
report to the Minister for Justice and Equality on an annual 
basis. In relation to drug issues, the Wheatfield Prison visiting 
committee in its 2011 annual report3 stated: ‘One of the 
most difficult problems for prisoners was in relation to family 
visits. Since the introduction of dogs to curb the introduction 
of drugs into the prison many visitors have failed to pass the 
dog test and therefore are only allowed screen visits. Many 
prisoners are unhappy with screen visits but we have to 
advise them that it is in the best interest of all prisoners that 
drugs are kept out of the prison.’ (p.4).
The Mountjoy Prison visiting committee in its annual report 
for 20114 also refers to the drug problems in the prison, 
including the issue of people becoming addicted in the 
prison. The report states:
We are particularly concerned at the increased level 
of tablet availability, and the difficulty in detecting 
these. Also the problem of interaction between drug 
users and non-drug users must be addressed in 2012. 
The incidences of prisoners becoming addicted in 
Mountjoy must be dealt with in a decisive manner. A 
drug free environment has got to be seriously worked 
on. The Visiting Committee is of the view that increased 
measures must be put in place to eliminate the passing 
of tablets etc. which cannot be detected by dogs. The 
introduction of nets over the yards has strengthened the 
controls on drug supplies, but desperation leads to some 
amazing inventions, as has been witnessed in Mountjoy 
over the years. So there is no room for complacency 
or relaxation in pursuing new ways of dealing with the 
issue of supply. A programme of dealing with addiction 
should be set up, so as to allow for far greater availability 
of treatment for drug users encouraged or wishing to 
come off drugs. It is astounding that prisoners locked up 
for 23 hours per day can still avail of a constant supply of 
drugs/tablets.’ (p.18)
With regard to the provision of treatment in the prison, 
the committee calls for a review of the drug treatment 
programme in the medical unit: 
The Medical Unit provides a primary pro-active care 
service, with a focus on preventive medicine. The 
facility provides for integrated programme for prisoners 
committed to becoming drug-free with a view to 
preparing for eventual release from prison. Prisoners 
wanting to participate in this programme are subject 
to specific qualifying considerations. We believe the 
programme should be widened to include all prisoners 
wishing to participate, who qualify. This whole area 
needs revision, as maybe it is time to look at the 
possibility of including all prisoners affected by drug 
addiction, in drug programmes. (p.17) 
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Drugs in focus – policy briefing
Drug demand reduction: global evidence for local actions
Cited from Drugs in focus, No. 23, 1st issue 2012
The development of evidence based demand reduction 
interventions is a primary drug policy objective at national, 
European Union (EU) and global level. A particular 
discourse, with its own set of concepts, is used to discuss 
implementation of this objective, including terms such 
as: best practice, quality standards, guidelines, protocols, 
accreditation systems and benchmarking. This paper 
provides readers with straightforward definitions of the 
terms used, whilst highlighting achievements and current 
challenges in transferring scientific knowledge into practice 
in the drug demand reduction arena. A special focus is 
given to ‘best practice’ because of this concept’s increasing 
popularity and importance in Europe.
The briefing concludes with a series of policy considerations:
1. Different tools are used to promote evidence based 
practices in drug demand interventions, such 
as guidelines and quality standards. Nationally, 
dissemination and adaptation of already existing 
evidencebased guidelines, rather than developing new 
ones, is proving to be a cost effective solution that helps 
to ensure quality. 
2. In the future, processes need to be in place to ensure 
that existing guidelines and standards are regularly 
updated as and when new evidence becomes available. 
In addition, the ongoing promotion and dissemination 
of guidelines and standards among professionals 
and decision makers is a key issue. Despite recent 
increases in the availability of scientific evidence on 
the effectiveness (and ineffectiveness) of drug related 
interventions, gaps still exist and research is required to 
fill these gaps. A European research agenda which gives 
priority to questions linked to both the effectiveness of 
interventions, and to improving the research practice 
interface, would be greatly welcomed. 
3. The EMCDDA with its experience in monitoring and 
disseminating best practice will continue to promote 
and support quality improvement in the European drugs 
field. Proactive dissemination of evidence,  
mentoring of guidelines adaptation, support in goal 
setting and impact evaluation and fostering the 
exchange of experiences are some of the activities  
we will continue to provide to stakeholders.  
www.emcdda.europa.eu/publications/drugs-in-focus
From Drugnet Europe
New drugs detected in the EU at the rate of around one 
per week 
Cited from article by Roumen Sedefov and Ana Gallegos in 
Drugnet Europe, No. 78, April–June 2012
New drugs were detected in the European Union last year at 
the rate of around one per week, according to the EMCDDA– 
Europol 2011 annual report on new psychoactive substances, 
released on 26 April. A total of 49 new psychoactive 
substances were officially notified for the first time in 2011 
via the EU early-warning system. This represents the largest 
number of substances ever reported in a single year, up 
from 41 substances reported in 2010 and 24 in 2009. In 
2011, the list of substances registered was dominated by 
two groups: synthetic cannabinoids (23 substances) and 
synthetic cathinones (8 substances), [which together] make 
up around two-thirds of the new drugs reported last year. All 
of the new compounds reported in 2011 were synthetic. The 
number of online shops offering at least one psychoactive 
substance or product rose from 314 in January 2011 to 690 
in January 2012. 
The Cloverhill Prison visiting committee 2011 report5 also 
refers to the need to establish a drug-free unit in the prison:
In our 2008 report we first suggested and strongly 
recommended exploring the possibility of establishing a 
Drug Free unit within this prison and again we strongly 
suggest exploring the possibly of doing a feasibility 
study. We are disappointed to note that there has been 
no developments in this area but accept that this may be 
difficult on a Practical level in a predominately remand 
setting. (p.22)
The 2011 annual report of the Prison Service6 states that 
supply control measures, including a security screening unit 
for visitors and staff members and a canine unit, ‘have been 
particularly effective and local intelligence indicates that the 
availability of contraband has significantly decreased across 
the prison system’ (p.31). The report also states that a drug-
free programme, to support prisoners who are drug free 
and/or stable on methadone, will be in place in all closed 
prisons (except Arbour Hill) ‘in dedicated drug free areas’ by 
the end of 2012 (p.30).
(Johnny Connolly)
1. Inspector of Prisons (2011) Report on an inspection of Limerick 
Prison by the Inspector of Prisons, Judge Michael Reilly, 25 
November 2011. Tipperary: Office of the Inspector of Prisons.
2. Inspector of Prisons (2012) Report of second follow up 
inspection of Limerick Prison by the Inspector of Prisons Judge 
Michael Reilly, 1 March 2012. Tipperary: Office of the 
Inspector of Prisons.
3. Wheatfield Prison Visiting Committee (2012) Wheatfield 
Prison Visiting Committee annual report 2011. Dublin: 
Department of Justice and Equality.
4. Mountjoy Prison Visiting Committee (2012) Mountjoy Prison 
annual report 2011. Dublin: Department of Justice and 
Equality.
5. Cloverhill Prison Visiting Committee (2012) Cloverhill Prison 
Visiting Committee annual report 2011. Dublin: Department 
of Justice and Equality.
6. Irish Prison Service (2012) Irish Prison Service annual report 
2011. Longford: Irish Prison Service.
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Monitoring responses to drug problems in Europe  
– a systemic approach
Cited from article by Alessandro Pirona and Dagmar Hedrich 
in Drugnet Europe, No. 78, April–June 2012
In most EU countries today, social-care providers, office-
based doctors and general health service professionals now 
complement work traditionally undertaken by caregivers 
from specialist drug treatment services. … Against this 
backdrop, the EMCDDA is adapting its treatment data 
collection approach and developing a new strategy for 
monitoring national treatment provision. 
In a new project involving experts from eight countries 
(Bulgaria, Czech Republic, Germany, Spain, Austria, Poland, 
Portugal and Switzerland), EMCDDA-commissioned 
consultants are testing the use of a generic map of national 
treatment systems. Using a standardised format for all 
countries, this will bring together data from different 
sources on multiple treatment providers (availability) and 
treated individuals (uptake). It is also flexible enough to 
accommodate specific components of national systems. 
The initial results of this pilot exercise will be available in the 
second half of 2012. 
Thematic paper on drug-related research 
Cited from article in Drugnet Europe, No. 78, April–June 2012 
Drug-related research in Europe: recent developments 
and future perspectives is the title of the next edition in 
the EMCDDA’s series of Thematic papers. Research can 
help answer policy questions by investigating the most 
appropriate interventions to help reduce drug problems. 
Today scientific findings and up-to-date evidence are 
important bases for sound policymaking at local, national 
and EU level. The EMCDDA has been monitoring drug-
related research since 2007. This paper, which draws on a 
variety of sources (e.g. Reitox national reports, EC-funded 
research projects), updates the EMCDDA’s 2008 Selected 
issue on National drug-related research in Europe. The new 
publication reports on recent developments and current 
challenges in the drug-related research field and suggests 
future opportunities.
Market share of herbal cannabis rising 
Cited from article in Drugnet Europe, No. 79, July – 
September 2012
‘The market share of cannabis herb is increasing across 
Europe, at the expense of cannabis resin’. This is according 
to the first comprehensive analysis of Cannabis production 
and markets in Europe, released in the EMCDDA Insights 
series. The report describes a cannabis market in a ‘continual 
state of evolution’ and how Europe, a major cannabis 
consumer, is now an important producer of this, its most 
popular illicit drug. Also documented is the wide variety 
of products on sale and how the rise in herbal cannabis 
cultivation inside Europe’s borders is increasingly associated 
with collateral damage, such as violence and criminality. 
The analysis shows that, in two-thirds of Europe (30 
EMCDDA countries), cannabis consumption is now 
dominated by herbal products (and by resin in the remaining 
third). Almost all (29) of the 30 reporting countries stated 
some cultivation of herbal cannabis. Considerable challenges 
posed by indoor cultivation techniques have led to a 
number of intelligence-led approaches to market interdiction 
involving new technologies and information sharing. Yet, 
most law enforcement attention is still focused on cannabis 
use rather than supply. For 
Social reintegration of drug users — a neglected issue 
Cited from article by Alessandro Pirona in Drugnet Europe, 
No. 79, July–September 2012
Although the quality and provision of drug treatment has 
improved significantly in the EU over the last two decades, 
most activities in this field remain predominately geared to 
managing or ending substance use. This has led to concerns 
that support aimed at (re)integrating socially excluded drug 
users is perhaps being neglected by current drug policies. …
Neglecting drug users’ social needs can undermine the gains 
made in treatment. In this light, the EMCDDA will release 
a study this autumn reviewing recent developments and 
best practice in the social (re)integration of problem drug 
users in treatment. The report will also examine evidence on 
the effectiveness of a large number of interventions aimed 
at boosting drug users’ employability and employment 
chances. On the same theme, a new module is under 
development in the EMCDDA’s Best practice portal 
dedicated to social (re)integration interventions. Due for 
release this autumn, these products are designed to help 
policymakers and practitioners further develop coherent and 
inclusive strategies to promote the social (re)integration of 
this target population.
Latest EMCDDA Thematic papers
Drug-related research in Europe: recent developments and 
future perspectives
Early warning system – national profiles
Responding to drug use and related problems in recreational 
settings
All three available at  
www.emcdda.europa.eu/publications/thematic-papers
From Drugnet Europe (continued)
Drugnet Europe is the quarterly newsletter of the European Monitoring Centre  
for Drugs and Drug Addiction (EMCDDA). Drugs in focus is a series of policy briefings published by the EMCDDA.  
Both publications are available at www.emcdda.europa.eu.
If you would like a hard copy of the current or future issues of either publication, please contact: 
Health Research Board, Knockmaun House,  
42–47 Lower Mount Street, Dublin 2.  
Tel: 01 2345 148; Email: drugnet@hrb.ie
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In brief
In recent months a series of reviews of structures and systems 
supporting the operation of the voluntary and community sector in 
Ireland have been initiated. While no final decisions have yet been 
taken, findings reported to date indicate both the need for a thorough 
overhaul and also the complexity of the issues.
August 2011: The Central Expenditure Evaluation Unit (CEEU) in the 
Department of Public Expenditure and Reform published a paper on 
rationalising multiple sources of funding for the not-for-profit sector. 
The authors questioned whether using a multiplicity of bodies is an 
efficient model for the delivery of services. The supported organisations 
employ a large number of people to administer the organisation itself 
and the funding provided. While the state is not employing any extra 
people, the state’s own funding methods contribute to the level of 
support required. They concluded:
 ■ The funding model whereby each agency receives part-funding 
from different state agencies, for different or overlapping objectives, 
serves neither efficiency nor effectiveness.
 ■ The number of state-to-agency transactions should be reduced, by 
rationalising both the number of bodies and the number of state 
interlocutors. In this context, one state body should be responsible 
for ‘core’ funding of each agency, and all state supports for the 
agency should be channelled through the one state body.
Central Expenditure Evaluation Unit (2012) CEEU cross-cutting paper 
no. 1: rationalising multiple sources of funding to not-for-profit sector. 
Dublin: CEEU, Department of Public Expenditure and Reform.
December 2011: The Minister for the Environment, Community and 
Local Government, Phil Hogan TD, established a high-level alignment 
steering group to review the role of local government in local and 
community development. In their interim report, published in 
December 2011, the steering group noted that existing arrangements 
for local development are administratively burdensome and do not 
lend themselves to joined-up, integrated service delivery, that the 
multiple structures set up by central government for service delivery 
at local level have, to a large extent, by-passed local government and 
undermined the democratic process at local level, and finally that there 
is considerable variation in approach, skills and standards of service 
delivery across both local authorities and local development companies. 
The group outlined their preferred ‘way forward’:
 ■ a more co-ordinated and integrated approach to local service 
provision, based on an enhanced role for local government in 
planning, decision-making, oversight and, where appropriate, 
delivery of local development programmes within agreed 
structures;
 ■ meaningful community engagement and involvement within this 
planning and decision-making framework as well as in the delivery 
of services;
 ■ a strong national oversight role to ensure consistency of standards 
and approaches across the country;
 ■ a more integrated and targeted approach to all the programmes 
funded and managed by all departments and agencies and 
delivered locally, through provision of joined-up services based on a 
comprehensive cross-programme and cross-government alignment; 
and
 ■ central government priorities should allow greater flexibility at local 
level to customise programmes and policy initiatives to local needs 
and priorities, while the policy making role at national level should 
also be informed by delivery and practice at local level. 
Local government / local development alignment steering group 
(2011) Interim report of the local government / local development 
alignment steering group. Dublin: Department of the Environment, 
Community and Local Government.
February 2012: The Minister of State in the Department of Health with 
responsibility for Primary Care, Róisín Shortall TD, initiated a review of 
drugs task forces, focusing on their role and composition, the national 
structures under which they operate and funding arrangements, and 
seeking, where appropriate, to transfer responsibility for funding task force 
projects to relevant statutory agencies and to overhaul the accountability 
and reporting arrangements of the drugs projects that continue to be 
supported by the task forces. To date, an interim report, issued in February 
2012, setting out the views of departments and statutory agencies, the 
voluntary and community sectors, and the drugs task forces themselves, 
shows a general consensus on the need for reform.
Drugs Programmes Unit (2012) Report on the consultation process in 
relation to the review of the structures underpinning the National Drugs 
Strategy. Dublin: Department of Health. 
April 2012: The European Anti-Poverty Network Ireland (EAPN Ireland) 
and OPEN published a case study of how the Irish government 
allocated grants to non-statutory organisations. Analysing the 
documentation held by the Department of the Environment, 
Community and Local Government with regard to the operation of 
a funding scheme supporting national organisations in the voluntary 
and community sector (2008–2010 and 2011–2013), the author found 
evidence of serious deficiencies in the quality of the administration of 
the scheme, details of which are reflected in his recommendations, 
including:
 ■ adopt a collegial approach among departmental officials to review, 
assessment and appeal;
 ■ undertake structured, strategic consultation with voluntary and 
community organisations;
 ■ improve the knowledge base, so that assessment and appeal 
officials are familiar with key governmental, academic and research 
texts on the profile, topography and modus operandi of the 
voluntary and community sector;
 ■ introduce guidelines for assessing concepts such as ‘disadvantage’, 
‘key services’, ‘coalface services’, and ‘added value’;
 ■ introduce mechanisms such as a technical assistance facility and/or 
a screening round to address the problem of poor applications;
 ■ use external advisers to assist in the assessment process;
 ■ apply the principles of administrative justice to the assessment and 
appeals system; and 
 ■ reinstate ‘advocacy’ as a factor for marking up the funding 
applications of voluntary organisations in the next round.
Harvey B (2012) Reforming grant-giving in public administration: the 
Funding scheme to support national organizations in the voluntary and 
community sector, a case study. Dublin: EAPN (European Anti Poverty 
Network) Ireland and OPEN.
June 2012: The Minister for Social Protection, Joan Burton TD, 
confirmed that she had received a copy of a review of the Community 
Employment (CE) scheme. The terms of the review were to examine 
the income and funding of sponsoring organisations in terms of their 
ability to continue the programme with reduced funding from the 
Department of Social Protection. She stated that one of the most 
important outcomes of the review was the identification of ‘very serious 
savings that could be made in areas such as administration in respect 
of insurance charges, and audit and accountancy charges. In the case 
of a number of CE schemes, it is also clear that rental savings may be 
possible.’
Burton J (2012, 12 June) Parliamentary Debates Dáil Éireann  
(Official report: unrevised): Priority questions. Community 
Employment schemes. Vol. 768, No. 1, p. 3. Question(s) 109, 110. 
 www.drugsandalcohol.ie/18184
(Compiled by Brigid Pike)
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Recent publications
Journal articles
The following abstracts are cited from recently published articles 
relating to the drugs and alcohol situation in Ireland.
Policy proposals for reducing alcohol-related harm: 
comparing and contrasting recent British and Irish policy 
documents
Butler S (2012)  
Drugs: education, prevention and policy, 2012,10 July. Early 
online. www.drugsandalcohol.ie/18060
The UK policy document The Government’s Alcohol Strategy 
(hereafter the GAS) was published in March 2012, just 
weeks after Ireland’s Department of Health published the 
Steering Group Report on a National Substance Misuse Strategy 
(hereafter the SGR). Despite its ambiguous title, the SGR is 
solely concerned with alcohol, specifically with how alcohol 
might be integrated into Ireland’s longstanding National Drugs 
Strategy, which prior to this had dealt only with illicit drugs. In 
a short commentary piece such as this it would be tedious, if 
not impossible, to present a point-by-point comparison of the 
two documents, but it might be of interest to readers in both 
jurisdictions to draw some broad comparisons between them. 
This will be attempted here by looking at the GAS and the SGR 
from three separate, if somewhat overlapping, perspectives: (1) 
their primary ideological content; (2) their policy status – either 
as proposals to government or government approved strategies 
and (3) the likelihood that all or most of the recommended 
strategies will be implemented.
Supportive text messaging for depression and comorbid 
alcohol use disorder: single-blind randomised trial
Agyapong VI, Ahern S, McLoughlin DM and Farren CK  
Journal of Affective Disorders, 2012, 29 March. Early online.  
www.drugsandalcohol.ie/17916
Mobile phone text message technology has the potential to 
improve outcomes for patients with depression and co-morbid 
Alcohol Use Disorder (AUD).This randomised rater-blinded trial 
aimed to explore the effects of supportive text messages on 
mood and abstinence outcomes for patients with depression 
and co-morbid AUD.
Fifty-four participants were randomised to receive twice daily 
supportive text messages (n = 26) or a fortnightly thank you text 
message (n = 28) for three months. Primary outcome measures 
were Beck’s Depression Inventory (BDI-II) scores and Cumulative 
Abstinence Duration (CAD) in days at three months. 
There was a statistically significant difference in three-month 
BDI-II scores between the intervention and control groups. 
There was a trend for a greater CAD in the text message group 
than the control group. Limitations of the study include the 
small sample size, the potential for loss of rater blinding and the 
lack of long term follow-up to determine the longer term effects 
of the intervention. The authors conclude that supportive text 
messages have the potential to improve outcomes for patients 
with comorbid depression and alcohol dependency syndrome.
Health impacts of increasing alcohol prices in the 
European Union: a dynamic projection
Lhachimi SK, Cole KJ, Nusselder WJ et al.  
Preventative Medicine, 2012,17 June. Early online.  
www.drugsandalcohol.ie/17915
Objective. Western Europe has high levels of alcohol 
consumption, with corresponding adverse health effects. 
Currently, a major revision of the EU excise tax regime is under 
discussion. We quantify the health impact of alcohol price 
increases across the EU. 
Data and method. We use alcohol consumption data for 
member states, covering 80% of the EU-27 population, 
and corresponding country-specific disease data (incidence, 
prevalence, and case-fatality rate of alcohol related diseases) 
taken from the 2010 published Dynamic Modelling for Health 
Impact Assessment(DYNAMO-HIA) database to dynamically 
project the changes in population health that might arise from 
changes in alcohol price. 
Results. Increasing alcohol prices towards those of Finland 
(the highest in the EU) would postpone approximately 54,000 
male and approximately 26,100 female deaths over 10 years. 
Moreover, the prevalence of a number of chronic diseases 
would be reduced: in men by approximately 97,800 individuals 
with diabetes, 65,800 with stroke and 62,200 with selected 
cancers, and in women by about 19,100, 23,500, and 27,100, 
respectively. 
Conclusion. Curbing excessive drinking throughout the EU 
completely would lead to substantial gains in population health. 
Harmonisation of prices to the Finnish level would, for selected 
diseases, achieve more than 40% of those gains.
Socio-demographic, environmental, lifestyle and 
psychosocial factors predict self rated health in Irish 
Travellers, a minority nomadic population 
Kelleher C, Whelan J, Daly L and Fitzpatrick P  
Health & Place, 2012, 18(2): 330–338  
www.drugsandalcohol.ie/17924
Irish Travellers are an indigenous nomadic minority group with 
poor life expectancy. As part of a census survey of Travellers 
(80%participation rate),a health status interview was conducted 
(n=2065,43.5% male).In the final regression model, positive 
predictors of self-rated health (SRH were having a flush toilet 
(OR2.2, p=0.021), considering where one lives to be healthy 
(OR1.9, p=0.017),travelling twice yearly (OR2.3 p=0.026), 
taking a brisk walk weekly (OR 2.4, p=0.000) and non-smoking 
(OR 1.7, p=0.03). Conversely, SRH was negatively associated 
with age (p=0.000), activity-limiting ill health (OR 0.4, p=0.001), 
or chronic health condition (OR0.4, p=0.002).
Effectiveness of a culturally adapted Strengthening 
Families Program 12–16 years for high-risk Irish families
Kumpfer K, Xie J and O’Driscoll R  
Child and Youth Care Forum, 2012, 41(2): 173–195  
www.drugsandalcohol.ie/17347
Cochrane Reviews have found the Strengthening Families 
Program (SFP) to be the most effective substance abuse 
prevention intervention. Standardized cultural adaptation 
processes resulted in successful outcomes in several countries. 
To promote wide-scale implementation and positive outcomes 
in Ireland, a unique model of inter-agency collaboration was 
developed plus guidelines for cultural adaptation with fidelity. 
250 high-risk youth and families were recruited to complete 
SFP and its parent questionnaire. All 21 measured outcomes 
had statistically significant positive results. Larger effect sizes 
were found for the Irish families than the USA families (d = 0.57 
vs. 0.48 for youth outcomes, d = 0.73 vs. 0.65 for parenting 
and d = 0.76 vs. 0.70 for family outcomes). Overt and covert 
aggression, criminality and depression decreased more in Irish 
youth, but the USA youth improved more in social skills. 
This study suggests that SFP 12–16 is quite effective in reducing 
behavioural health problems in Irish adolescents, improving 
family relationships and reducing substance abuse. Additionally, 
the Irish interagency collaboration model is a viable solution 
to recruitment, retention and staffing in rural communities 
where finding five skilled professionals to implement SFP can be 
difficult. 
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Upcoming events
(Compiled by Joan Moore – jmoore@hrb.ie)
October
18 October 2012
Pillars of Protection: Strengthening Families, 
Strengthening Communities
Venue: Gresham Hotel, O’Connell Street, Dublin  
Organised by / Contact: Ballymun Local Drugs Task Force / 
Clíodhna Murphy  
Email: cliodhna@ballymundtf.ie  
Tel: 01 883 2124 
Information: The theme of this one-day conference is 
‘Exploring the evidence for family based prevention through the 
implementation of the Strengthening Families Programme in 
community settings across Ireland’.
Speakers include: Henry Whiteside (Lutra Group, USA), 
Róisín Shortall (Minister of State, Department of Health), and 
representatives of the Probation Service, Le Chéile, the HSE and 
more. The conference is aimed at community, statutory and 
voluntary services and practitioners, schools, policy makers, 
academics, volunteers, and others with an interest in family-
based prevention and/or Strengthening Families Programme. 
November
6 November 2012
A question of balance: delivering an inclusive treatment 
and recovery system DrugScope Conference 2012
Venue: Connaught Rooms, Great Queen Street, London WC2B 
5DA  
Organised by / Contact: DrugScope  
Email: conferences@drugscope.org.uk  
www.drugscope.org.uk/events
Information: In every cliché, there is a large element of truth, 
so we make no apologies for emphasising that ‘there are many 
ways into addiction and many ways out of it’. But for people 
to find the right path for them, all paths have to be open 
and we have an obligation to deliver a balanced and holistic 
treatment and recovery system which is not driven by either 
cash or ideology. To that end, we have speakers who will cover 
the spectrum from harm reduction and substitute prescribing 
to abstinence-based services, and workshops looking at the 
needs of special groups, such as the older user. Other topics will 
include: latest new drugs to hit the streets; service provision for 
LGBT clients; and best practice in residential rehabilitation.
8–9 November 2012
Society for the Study of Addiction: Annual Symposium 
2012
Venue: Park Inn Hotel, York, UK  
Organised by / Contact: Society for the Study of Addiction  
Tel: +44 (0) 113 295 2787  
www.addiction-ssa.org/ssa_10.htm
Information: The symposium will address the following themes: 
emerging challenges in addiction psychiatry; alcohol harms, 
interventions and policy; and the research base for policy. Dr 
Bruce Ritson will give the Society Lecture on alcohol policy and 
its implementation in Scotland, with an historical perspective. Dr 
Bridgette Bewick will present ‘Delivering personalised feedback 
and/or social norms information via the internet: promoting 
change in alcohol and other drug use’. The full programme will 
be posted on the society’s website in due course.
8–10 November 2012
2nd International NEAR Conference
Venue: Powerscourt Ritz Hotel, Enniskerry, Co Wicklow  
Organised by / Contact: Toranfield House and Southworth 
Associates  
www.nearconference.com
Information: Toranfield House and Southworth Associates will 
host Ireland’s 2nd International Conference and Exhibition on 
behavioural health, including addiction disorders. Delegates will 
be introduced to new concepts and ideas from international 
and local speakers and will leave the three day conference with 
an understanding of what the latest neurobiological research 
illustrates about addiction and an understanding of the latest 
evidence-based practices associated with treatment.
21 November 2012
Mental health, young people and suicide 
Venue: Civic Center, Mellowes Road, Finglas  
Organised by / Contact: CityWide / Iris Lyle / Larry Dooley  
Email: iris.lyle@tap.ie / larry.dooley@dublincity.ie  
Tel: 01 851 4121 / 01 222 5404
Information: The last in a series of lectures arising from the 
2011 seminar ‘Promoting mental wellness for young people in 
Finglas’. Dr Gerry McCarney of SASSY ( Substance Abuse Service 
Specific to Youth) will deliver this lunchtime lecture (12.30pm–
1.15pm).Please email organisers if you plan to attend.
28–30 November 2012
7th Annual Manchester Women’s Conference: Women 
and addiction
Venue: Hulme Hall, Manchester M14 5RR  
Organised by / Contact: Manchester Women’s Conference / 
Carol Rayegan  
Email: carol.rayegan@manchester.ac.uk  
Tel: +44 (0) 161 275 0714
Information: Men are more likely than women to become 
addicts. However, nearly 30% of those now in touch with 
services are women. This presents a real challenge for 
interpreting evidence, developing policy or designing services 
for women with addictions. The 7th Annual Manchester 
Women’s Conference aims to develop understanding needed 
to create services that can address the specific needs of women 
with addiction.
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